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Abbreviations
Abbreviations used are as recommended in the Biochem ical Journal 
Instructions to  Authors, 1981, w ith  the fo llow ing  additions:
A Ï: angiotensin I
BAEE: benzoyl arginine e thy l ester
SBTI: soybean trypsin inh ib ito r
SDS: sodium dodecyl sulphate
TEMED N ,N ,N ',N '-te tram ethyle thylenediam ine
H.77: D -H is-P ro-P he-H is-Leu^Leu-Va l-T  yr
H.77 is an analogue of the H is^-T yr^^  octapeptide 
sequence o f equine angiotensinogen in which the N - 
te rm ina l h istid ine residue has been replaced w ith  D - 
histid ine and the cleavage s ite  has been m odified by 
the in troduction  o f a reduced peptide bond (R: -CHg- 
N H -) in place o f the peptide bond norm ally cleaved 
by renin.
I O C
In  the descrip tion  of I - la b e l le d  compounds, the use of c irc u la r  
brackets does not imply th a t a l l  the iodine was the ra d io ac tive  isotope
D e fin itio n  o f enzyme units
A cid  proteinase: one unit o f a c t iv ity  was defined as the a c tiv ity  exhib ited
by lu g  o f pure human spleen cathepsin D in the assay system described in
Section 2.4(c).
Human ren in : one un it o f human renin (MRC reagent 68/356) generated
angiotensin I a t a ra te  o f 182.8pg/h in the assay system described in Section
2.4(a).
Pig ren in ; one un it o f pig renin (MRC reagent 65/119) generated
angiotensin I at a ra te  o f 96.2 pg/h in the assay system described in Section
2.4(a).
Trypsin: one BAEE un it o f trypsin a c t iv ity  was defined as the
a c tiv ity  required to  produce an increase in ex tinc tion  at 253nm of 0.001/m in
under the assay conditions described in Section 2.4(d).
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SU M M A R Y
1. A new a f f in ity  column fo r renin was prepared by coupling the isosteric 
peptide in h ib ito r o f renin, H.77 (D -H is-P ro-Phe-H is-Leu5Leu-Va l-Tyr, where R is 
a reduced peptide bond, -C H 2 -N H -), to activated 6-aminohexanoic acid-Sepharose 
4B. Chrom atography o f a crude ex tra c t o f human kidney cortex on th is 
m ate ria l resulted in a 5,500-fold pu rifica tion  o f renin in 76% yie ld . The 
purified  enzyme (specific  a c t iv ity  871 units/m g) was free  o f non-specific acid 
proteinase a c t iv ity  and was stable at pH 6.8 and -20°C  over a period o f several 
months. Exam ination o f th is preparation by electrophoresis in the presence o f 
0.1% (w /v) SDS showed th a t i t  contained both renin (Mp 40,000), and an 
un iden tified  prote in o f Mp 17,000.
2. An inactive  fo rm  o f renin was purified  from  human renal cortex using a
com bination o f chromatography on H.77-Sepharose (to remove active  renin),
ammonium sulphate frac tio na tion , hydrophobic in te rac tion  chromatography and 
a ff in ity  chromatography using a monoclonal immunoadsorbent. This procedure 
resulted in a 14,750-fold pu rifica tion  o f inactive  renin in 27% yie ld . The 
pu rified  prote in was stable at pH 7.4 and -20°C  over a period o f several
months. Exam ination o f th is  preparation by electrophoresis in the presence o f 
0.1% (w /v) SDS showed tha t i t  consisted o f a single polypeptide chain o f Mp
48,000. An Mp value o f 51,000 was obtained by gel f i lt ra t io n .
The purified  inactive  renin was com plete ly inactive  against ox
angiotensinogen, but could be activa ted  by lim ite d  proteolysis. Trypsin 
trea tm en t o f inactive  renin produced an active form  o f renin (Mp 47,000 by gel 
f i lt ra t io n )  w ith  a specific  a c t iv ity  o f 708 units/m g inactive  renin . Inactive  
renin could also be activa ted  by dialysis to pH 3.3. However, ac id ified  
inactive  renin was re -inac tiva ted  by dialysis back to  neu tra l pH.
3. A s truc tu ra l comparison o f active  renin and inactive  renin was carried
iJ ,
out by peptide 'mapping' o f ^^^I-labe iled  samples o f the pu rified  proteins. One 
dimensional peptide mapping o f the labelled proteins in polyacrylam ide gels 
(Cleveland mapping) suggested a s truc tu ra l s im ila r ity  between the two form s o f 
renin. Analysis o f V8 proteinase digests o f the labelled proteins by reverse 
phase high perform ance liqu id  chormatography indicated th a t there are extensive 
regions o f common sequence in the active  and inactive  form s o f renin.
4. The results obtained in the present study ind ica te tha t inactive  renin is 
a renin zymogen.
14,
C H A P TE R  1 
IN T R O D U C T IO N
Renin (EC 3.4.99.19) is a highly specific  endoproteinase which is 
synthesised m ainly in the juxtag lom eru lar cells of the a ffe ren t glom erular 
a rte rio le  o f the kidney. I t  is released from  the kidney in to  the c ircu la tion  
where i t  cleaves the a 2 -g lobulin angiotensinogen to produce the inactive  
decapeptide, angiotensin I. Subsequently, angiotensin I is cleaved by a peptidyl 
d ipeptide hydrolase (converting enzyme) to give the vasoactive octapeptide, 
angiotensin II, which has numerous actions concerned w ith  sodium and flu id  
homeostasis and w ith  the maintenance of blood pressure (Figure 1.1) (Brown ^  
^ . ,  1983; Leckle and Semple, 1983).
P rio r to 1970, renin was thought to be an acid-stable enzyme o f Mp
40,000. A lthough there were suggestions tha t an enzym atica lly  inactive  
precursor o f renin m ight exist (Meyer et ^ . ,  1965; de V ito  et 1970) d irec t 
evidence was lacking. The only variants seen were form s d iffe r in g  s ligh tly  in 
th e ir isoe lec tric  points (Skeggs et al .^, 1967). The discovery by Lumbers (1971) 
o f an inactive  fo rm  of renin which could be activa ted  by ac id ifica tion  was 
there fo re  o f m ajor in te rest. Since then, high m olecular weight form s o f renin 
which can be activa ted  by ac id ifica tion , lim ite d  proteolysis, or exposure to  low
temperatures, have been found in the kidneys and plasma of several species,
including man. The lite ra tu re  concerning the subject has become extensive and 
reviews have been published by Inagami and Murakami (1980), by Seeley et
(1980) and by Leckie (1981). However, despite a decade o f intensive research,
neither the precise chem ical nature o f the possible precursor form s of renin nor 
th e ir physiological im portance are c learly  understood.
1.1 P u rific a tio n  and properties of renin
Although renin was discovered by T igerstedt and Bergman in 1898, i t  has
Pressor effect 
Sympathetic stimulation
ADH secretion
Angiotensinogen
Renin
Angiotensin I
Converting enzyme
Angiotensin I I
Renal actions
Aldosterone secretion
Thirst
Figure 1.1 O u tlin e  of the renin-angiotensin system and some of the
main actions of angiotensin I I .
been pu rified  to  homogeneity only recently . E arly  attem pts at renin 
p u rifica tion  were hindered by the extrem ely low concentrations of renin in the 
kidney, and by the in s ta b ility  o f the enzyme during p u rifica tio n  (Peart e t ah,
1966). However, the application o f a f f in ity  chromatography to th is problem,
and in pa rticu la r the use o f the acyl at ed pentapeptide pepstatin as an a f f in ity
ligand, has resulted in the complete pu rifica tion  o f renin from  hog (Murakami
and Inagami, 1975; Corvol ^  1977; Inagami and M urakam i, 1977), ra t
(Matoba ^  a[., 1978), dog (Dzau et 1979) and human (Yokosawa et 1978; 
S later et 1978; Yokosawa et 1980) kidney.
Renin or ren in -like  enzymes are present in a va rie ty  of extra rena l
tissues including the uterus and placenta (Symonds et ah, 1968), am niotic f lu id
(Brown e t 1964), adrenal gland (Naruse et 1983), vascular walls (Re ^  
a l., 1982) and brain (Inagami ^  al., 1982a). Renin is also present in the 
subm axillary gland (Bing et ^ . ,  1980). In the mouse, the synthesis o f
subm axillary gland renin is under both genetic and hormonal contro l and in 
certa in  strains o f m ice the enzyme may represent up to  5% of the to ta l prote in 
content o f the gland (Wilson et 1977; Wilson et 1981; Wilson ^  al_., 
1982). A lthough the physiological relevance o f this phenomenon is unknown, i t  
has allowed the p u rifica tion  o f renin in su ffic ie n t quantities to allow  the 
determ ination o f its  prim ary s tructu re  (Misono et ah, 1982).
The properties o f purified  subm axillary gland renin and those o f the
purified  renal enzymes are summarised in Table 1.1.
Renin is a member of the aspartic proteinase group o f enzymes which 
also includes pepsin, chymosin, cathepsin D and various m icrob ia l proteinases. 
L ike  these enzymes, renin possesses two carboxyl groups which are essential fo r 
catalysis. The chem ical m od ifica tion  of e ither o f these groups leads to an 
irrevers ib le  loss o f enzyme a c tiv ity . Thus, renin is inactiva ted  by l,2 -epoxy-3- 
(p-nitrophenoxy)propane and by active site d irected diazo compounds (McKown
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and Gregerman, 1975; Misono and Inagami, 1980).
The prim ary structu re  o f mouse subm axiliary gland renin has been
determ ined both by the analysis o f the purified  enzyme (Misono et 1982) and
by the sequencing o f the renin gene (Panthier et a l., 1982a). The amino acid 
sequence o f th is enzyme shows considerable homology w ith  the sequences of 
other aspartic proteinases. The sequence id en tity  w ith  porcine pepsin is 43%. 
Renin is also homologous w ith  chymosin (34% id en tity ) and w ith  peniciilopepsin 
(22% iden tity ).
Compared w ith  other aspartic proteinases, renin shows a highly res tr ic ted  
substrate sp e c ific ity . A lthough renin w ill cleave a number o f synthetic peptide 
substrates (Skeggs et ^ . ,  1957; Reinharz and Roth, 1969; Murakami ^  ah,
1981), the only known natura lly  occurring renin substrate is angiotensinogen. 
The amino te rm ina l sequences o f equine, human and ra t angiotensinogens are 
shown in Table 1.2. The m inimum peptide sequence required fo r substrate
a c t iv ity  appears to be the 6-13 octapeptide (Skeggs et 1957). Renin
spec ifica lly  cleaves the peptide bond between the amino acid residues at 
positions 10 and 11. In the horse and the ra t, th is  is a leucyl-leucine bond. 
Human angiotensinogen has a leucyl-va line scissile bond. These differences are 
re fle c ted  in the species s p e c ific ity  o f the renin-substrate reaction. Human 
angiotensinogen is cleaved only by human renin, whereas other mammalian 
angiotensinogens are cleaved by both human and animal renins.
The purified  animal renins have a broad pH optim um  in the range pH 5.5
to pH 7.0 when tested w ith  homologous renin substrates, although both higher
and lower pH optim a can occur w ith  heterologous substrates or synthetic peptide
substrates (Inagami et 1977b). Human kidney renin has a somewhat
narrower pH optimum w ith  its  homologous substrate at about pH 6.0 (Yokosawa 
et 1980).
Hog renin contains glucosamine and, w ith  the exception of subm axillary
Table 1.2
Comparison o f the N -te rm in a l sequences o f equine, 
human and ra t  angiotensinogens
1 2 3
Horse ® asp arg val
Human ^ asp arg val
Rat c asp arg val
K ey a. Data from
b. Data from
G. Data from
Renin
I
10 11 12 13 14
his thr
gland renin, a ll mammalian renins appear to be glycoproteins based on th e ir 
a b ility  to  bind to concanavalin A-Sepharose (Matoba et sd., 1979; Yokosawa ^  
a l., 1980) or on a positive S ch iff reaction (Corvol e t 1977). The pu rified  
renal renins consist o f a single polypeptide chain and have M^ values in the 
range 38,000-42,000 when measured by gel f i lt ra t io n . S ligh tly  lower Mp values 
(35,000-37,000) have been obtained fo r hog, ra t and dog renal renins using 
SDS/polyacrylam ide gel electrophoresis or by sedim entation equilibrium  analysis 
(Inagami and M urakam i, 1977; Matoba et ^ . ,  1979; Dzau et ^ . ,  1979). Mouse 
subm axillary gland renin consists o f two polypeptide chains (A,Mp 30,000 and 
B,Mp 5,500) linked by a disulphide bond (Misono and Inagam i, 1982).
1,2 B iosynthetic  precursors o f renin
Many proteins are synthesized as inactive precursors or zymogens which 
are subsequently converted to active form s by lim ite d  proteolysis. This is true  
fo r a large number o f ex trace llu la r proteinases including pepsin and chymosin, 
the best characterised o f the aspartic proteinases. Pepsin, fo r  example, is 
secreted by the ch ie f cells o f the gastric mucosa as the zymogen pepsinogen. 
In the acid environm ent o f the stomach, pepsinogen is converted to pepsin both 
by an in tram o lecu la r reaction and by an in te rm olecu lar reaction involving newly 
form ed pepsin (Hartsuck e t 1977). During th is conversion, several peptides 
containing a to ta l o f 44 amino acid residues are removed from  the amino 
te rm ina l end o f pepsinogen.
In recent years i t  has become apparent th a t renin is also synthesized as 
a precursor.
Most eukaryote secretory proteins possess, during transla tion, an amino 
te rm ina l extension of about 16 to 25 amino acid residues. This 'pre-' or 'signal’ 
sequence d irects the nascent polypeptide through the membrane o f the 
endoplasmic re ticu lum  in to the c isternal space fo r eventual secretion o f the 
prote in from  the ce ll (Blobel and Dobberstein, 1975). A membrane bound signal
peptidase cleaves the signal peptide from  the growing polypeptide chain shortly  
a fte r  i t  enters the lumen o f the endoplasmic re ticu lum  and thus 'preproteins' 
ra re ly  exist jn  v ivo . They can, nevertheless, be demonstrated using ce ll-fre e  
trans la tion  systems, which are devoid o f hyd ro ly tic  enzymes,
Poulsen e t aj_. (1979b), using ren in -specific  antibodies to examine the 
products o f ce ll-fre e  transla tion of mouse subm axillary gland mRNA, have 
demonstrated the existence of a renin precursor o f Mp 50,000. More recen tly , 
Lund et ah (1982) have found tha t a s ligh tly  sm aller renin precursor o f Mp
48.000 is produced by the transla tion o f subm axillary gland mRNA m icro in jected 
in to  Xenopus laevis oocytes. Since Xenopus oocytes can remove signal peptides 
from  the transla tion  products o f non-Xenopus mRNAs (J ilka  et a l., 1979), these 
results ind ica te  tha t the prim ary transla tion product o f the renin gene contains 
a signal sequence of Mp 2,000.
A s im ila r find ing  has been reported by Dzau e t (1982). These 
authors found tha t the translation of mouse subm axillary gland mRNA by a 
rabb it re ticu lo cy te  lysate yielded an Mp 48,000 'preprorenin '. The addition o f 
dog pancreatic microsomes, which contain signal peptidase a c tiv ity , resulted in 
the conversion o f the preprorenin to  a renin precursor o f Mp 46,000. The 
same authors carried out pulse labelling experiments in which the biosynthetic 
incorporation o f ^^S-methionine in to  renin was studied using cultured mouse 
subm axillary gland tissue. In these experiments, the renin precursor o f Mp
46.000 or 'prorenin ' was form ed w ith in  minutes. This was slow ly converted to  
a renin o f Mp 37,000 which was the sole form  secreted in to  the culture medium.
The existence o f 'pre' and 'pro' sequences in the prim ary transla tion 
product of mRNA coding fo r renin has been confirm ed by examination o f the 
J o r  I'eruA J'rojn. 5 ujb<naxdL(>i  ^ /i-vû'o^se (Panthier ^  ^ . ,  1982a).
A model fo r the post-translationa l processing o f renin based on this sequence 
and on the s truc tu re  o f pure subm axillary gland renin is shown in Figure 1.2.
Nascent Polypeptide 
A B D C
I I  I  I
Met Cys Thr Lya Arg Ser Asn Arg Arg Asp Arg
1 18 19 62 63 64 351 352353 354 401
I Pre I Pro I Renin a
Mature Renin
S   S S ' S s —   i ' ■ s
I t  i l l  I
64 114 121 277 281 320 351 354 357 401
[ A chain B chain
Figure 1.2 Schem atic representation o f the possible m aturation
process of mouse subm axillary gland renin ®
Subm axiliary gland renin is synthesized in it ia lly  as pre prorenin which is rap id ly 
converted to  prorenin by removal o f the signal peptide (cleavage A). Prorenin 
is converted to m ature renin by two p ro teo ly tic  cleavages fo llow ing  dibasic 
peptides (cleavages B and C) and by removal o f the A r g 352 _ A rg^^^ dipeptide 
(cleavage D). This produces the A and R renin chains which are linked by a 
disulphide bond.
® data taken from  Misono et al. (1982), Panthier et al. (1982a) and Corvol et al, 
(1983).
This model involves the cleavage o f the 'pre' and 'pro’ sequences from  the 
nascent renin polypeptide and the fu rth e r cleavage of renin to  produce the A 
and B chains o f mouse subm axillary gland renin.
There is some evidence to suggest tha t precursors o f renin are also 
form ed during its  biosynthesis in the kidney. The gene coding fo r  mouse 
subm axillary gland renin has arisen by duplication o f the gene coding fo r the 
kidney enzyme (Panthier et 1982b). This appears to  be a fa ir ly  recent 
event in evolutionary term s and thus i t  is like ly  th a t the prim ary transcrip ts of 
the two genes are very s im ila r in s tructure , Poulsen et (1980) have shown 
th a t, as in the case o f mouse subm axillary gland renin, a 'preprorenin' o f Mj.
50,000 is form ed by the ce ll- fre e  transla tion o f mouse kidney mRNA. More 
recen tly , Parm entier et (1983) have obtained a 'preprorenin' o f Mp 45,000 by 
the c e ll- fre e  trans la tion  o f human kidney mRNA. A b iosynthetic precursor o f 
kidney renin (Mp 55,000) has also been detected by Carlson et (1981), using 
isolated canine glom eru li in cu lture . Pulse-chase studies showed tha t th is 
precursor was converted in to  m ature renin of Mp 38,000 over a period o f hours.
The post-transla tiona l processing of kidney renin must d iffe r  s lig h tly  
from  tha t o f the mouse subm axillary gland enzyme, both because the renal 
enzyme is glycosylated, and because i t  consists o f a single polypeptide chain 
ra the r than two dlsulphide bonded chains. Nevertheless, i t  seems probable tha t 
'prepro' and 'pro' form s o f the enzyme exist, at least trans ien tly , during its  
biosynthesis.
1.3 High m olecular w eight and inactive  form s of renin
The _in v itro  demonstration of a biosynthetic precursor of renin does not 
necessarily im ply tha t such a precursor exists jn  vivo as an inactive  zymogen.
Renin is stored w ith in  juxtag lom eru lar cells in granules (Cook and 
P ickering, 1962). These granules sediment w ith  the m itochrondria l and
lysosomal fractions during the d iffe re n tia l cen trifuga tion  o f kidney cortex
extracts  (Ogino e t 1967; Nustad and Rubin, 1970), but can be separated 
from  other subcellu lar organelles by density gradient cen trifuga tion  (Sagnella and 
P eart, 1979). Granules prepared using th is method (Sagnella et 1980; 
M urakam i et ^ . ,  1980b), or by u ltra f ilt ra t io n  o f crude kidney cortex extracts  
(Funakawa et aL, 1978) contain a single form  of renin o f Mp 40,000. However, 
many investigators have shown tha t crude extracts of kidney cortex contain, in 
addition to  the form  o f renin o f Mp 40,000, one or more high molecular weight 
form s of renin. Some o f the high molecular weight form s o f renin described in 
the lite ra tu re  appear to  be complexes o f renin w ith  a renin binding prote in, 
w h ile  others may be biosynthetic precursors of renin analogous to zymogens such 
as pepsinogen or trypsinogen.
(a) Protein-bound form s of renin
The Mp 40,000 form  of renin in dog (Funakawa ^  ^ . ,  1978), pig 
(Murakam i ^  ^ . ,  1980b), ra t (Sagnella et 1980) and mouse (Iwao et a l.,
1982) kidney cortex can be converted to  a higher m olecular weight form  o f the 
enzyme by in te rac tion  w ith  an acid-lab ile  binding prote in. The form ation o f 
the ren in-renin binding prote in complex occurs spontaneously in crude kidney 
extracts, even at low tem peratures (Kawamura ^  1980). However, i t  is
grea tly  enhanced by reagents which e ithe r oxidise or a lky la te  sulphydryl groups 
(Funakawa £ t  1978). Thus, renin can be extracted  almost entire ly in the 
high m olecular weight form  i f  N -e thy l m aleim ide is included in the extraction  
m ix tu re  (Inagami et 1977a).
N e ither the true  size o f the renin-renin binding pro te in  complex nor its  
s to ich iom etry  are clear at present. The complex dissociates during gel 
f i l t ra t io n  giving rise to  an e lu tion peak which corresponds to an Mp value o f 
around 60,000 (Ueno et aL, 1981). An Mp value o f 113,000 has been obtained 
by sedim entation equ ilibrium  analysis o f a crude preparation o f the pig kidney 
ren in-renin binding prote in complex (Ueno et al., 1981) and th is is consistent
w ith  the find ing  tha t the renin binding prote in has an Mp value in excess o f
47,000 by gel f i l t ra t io n  (Kawamura e t aL, 1979; Yamam oto e t ai., 1980; 
Sagnella e t 1980; Ueno et aL, 1981). Recently, however, Takahashi e t 
(1983) have obtained an Mp value of 42,000 by SDS/polyacrylamide gel 
electrophoresis fo r  pu rified  pig renin binding prote in . These authors suggested
th a t the ren in-renin binding prote in complex consists o f equimolar amounts o f 
renin and the binding prote in , giving an Mp value o f around 80,000 fo r  the 
complex. A lte rn a tive ly , i t  is possible tha t two molecules o f binding prote in 
associate w ith  each renin molecule to  give a complex o f Mp 120,000.
A lthough renin binding proteins have been found in the renal cortex o f
a ll animal species tested, th e ir  physiological function  remains obscure. The 
binding prote in isolated from  pig renal cortex is an in h ib ito r of the renin-renin 
substrate reaction (Ueno et 1981; Takahashi et 1983). However, there
is no evidence tha t i t  has a d irec t in h ib ito ry  function  Jn v ivo . Takaori e t 
(1982) have suggested tha t the renin binding prote in may play a role in the 
reaLsorption of renin f ilte re d  from  the c ircu la tion  by the glomerulus.
(b) Possible precursor form s of renin
Evidence th a t an inactive  precursor o f renin m ight exist was f ir s t
obtained during studies on renin synthesis and release by the ra t kidney (de V ito  
et aL, 1970). In these experiments, kidney slices were incubated in cu ltu re
medium in the presence o f the prote in synthesis inh ib itors, actinom ycin D and 
puromycin. Over a 7 hour incubation period, renin was released in to the 
medium in an amount which represented about 75% of the orig inal a c t iv ity  
present in the slices. However, although protein synthesis was inhib ited, there 
was no detectable decrease in the renin content of the tissue. De V ito  
suggested th a t th is result was due to the activa tion  o f an inactive  'prerenin'.
D ire c t evidence fo r the existence o f an ac tiva tab le  fo rm  o f renin was 
provided by Lumbers (1971) who showed tha t am nio tic flu id  dialysed to a pH of
3.3 and then back to  pH 7.4 had a higher renin concentration than am nio tic
f lu id  dialysed to a pH above 4.0. Since then, many workers have reported tha t
jzLu-cL
an increase in the measured renin concentration o f human am niotic^and plasma 
occurs a fte r exposure to a pH of between 3.0 and 3.3, fo llow ed by dialysis to  
neutra l pH (Skinner et 1972; Day and Luetscher, 1974; Leckie ^  aL, 1977; 
Derkx et ^ . ,  1976; Boyd, 1977). The amount by which the measured plasma 
renin concentration increases, and by inference, the amount o f inactive renin 
present, depends on the source o f the plasma. In man, between 70% and 90% 
o f the to ta l c ircu la ting  renin is present as an inactive  fo rm  of the enzyme 
(Cooper et 1976; Derkx ^  1976). Values o f 15% fo r ra t plasma
(Vandongen ^  ^ . ,  1977), 20% fo r  rabb it plasma (Richards e t ^ . ,  1981), 50% fo r 
sheep plasma (Lush e t 1983), 80% fo r pig plasma (Bailie  et 1979), and 
33% fo r  dog plasma (James and H a ll, 1974) have been reported although, in the 
la tte r  case, i t  is not clear th a t the increase in angiotensin I generating a c t iv ity  
observed a fte r  ac id ifica tion  is due solely to  the ac tiva tion  o f inactive renin 
(Sealey e t 1980).
Plasma inactive  renin can also be activa ted  by exposure to low 
temperatures. Cold trea tm en t o f human plasma at -5°C  fo r 4 days results in 
an increase in renin a c t iv ity  (Osmond et 1973; Sealey e t aL, 1976), but to  a
lesser exten t than a fte r acid trea tm en t (A tlas et  ^ ^ . ,  1978; Hsueh et 1978). 
L i t t le  or no increase in the renin a c t iv ity  o f plasma occurs a t 4°C (Hsueh et 
^ . ,  1978; M illa r  et ^ . ,  1980).
The increase in plasma renin a c tiv ity  resu lting from  the above 
manipulations is irrevers ib le  and has been shown to depend on the presence of 
endogenous serine proteinases (A tlas e t 1978; D erkx et a^., 1978a; Leck ie ,
1978). Plasma serine proteinase a c t iv ity  is norm ally m aintained at low levels 
by c ircu la ting  proteinase inh ib itors. However, many o f these inhib itors are 
inactiva ted  by ac id ifica tion . The dialysis o f plasma to acid pH, there fo re .
results in an increase in serine proteinase a c tiv ity  which activates inactive renin 
when the plasma is returned to neutra l pH (Derkx et 1982; Sealey e t a l., 
1982a). Cold trea tm en t o f plasma is thought to reduce the potency o f plasma 
proteinase inh ib ito rs , thus allow ing endogenous serine proteinases to slow ly 
ac tiva te  inactive  renin (Sealey et 1982a).
Plasma inactive  renin can be activa ted Jn v itro  by a varie ty  o f 
proteinases (Leckie, 1981; Inagami e t ^ . ,  1982b), including certa in  enzymes of 
the coagulation and f ib r in o ly t ic  systems, as w e ll as a number o f tissue 
proteinases. An inactive  fo rm  of renin which can be activa ted by lim ite d  
proteolysis is also present in hog and human renal cortex, and in the perfusate 
from  human kidneys (Murakami et 1980c; A tlas et 1980). This has led 
some investigators to suggest tha t inactive  renin is a renin zymogen tha t is 
activa ted  e ithe r w ith in  the c ircu la tion , or at sites d ista l to  its  site o f synthesis 
(Schaiekamp and Derkx, 1981; Sealey et aL, 1982a). A lte rn a tive  possibilities 
tha t must be considered, however, are tha t inactive  renin is a protein bound 
fo rm  o f renin or tha t i t  is a ren in -like  enzyme which is activa ted by lim ite d  
proteolysis.
Angiotensinogen can act as a substrate fo r enzymes other than renin, 
such as pepsin (De Fernandez e t aL, 1965) and cathepsin D (Hackenthal e t ^ . ,  
1978). Angiotensin I generating a c tiv itie s  which are not inh ib ited  by an ti-ren in  
antibody, and which d iffe r  from  renin in the ir pH optim a, or reaction k inetics, 
have been found in the brain (Day and Reid, 1976; Dzau et aL, 1980), kidney 
(Hackenthal ^  aL, 1978), blood vessel walls (Thurston e t a l., 1978) and adrenal 
gland (Naruse et ^ . ,  1983). T rypsin -activa ted renins from  human plasma and 
kidney, however, are s im ila r to purified  renal renin w ith  respect to the ir pH 
optim a, reaction  k inetics, sp e c ific ity , and inh ib ition  by pepstatin. Moreover, 
tryps in -ac tiva ted  inactive  renin and endogenous active  renin are inh ib ited  
id e n tica lly  by m onospecific an ti-ren in  antibodies (A tlas et ^ . ,  1982b; Hsueh et
a l., 1983). I t  seems unlike ly, there fo re , tha t the a c t iv ity  produced by lim ite d  
proteolysis o f inactive  renin is due to  a non-renin proteinase.
L i t t le  is known about the s truc tu ra l re lationship between the active and 
inactive  form s of renin. As expected fo r a renin zymogen, human inactive  
renin is com ple te ly inactive  against renin substrate and is s ligh tly  larger than its  
active  counterpart (Sealey et ^ . ,  1982a). Mj, values of around 50,000 and
56,000 have been obtained by gel f i l t ra t io n  fo r kidney and plasma inactive renin, 
respective ly. HoweVer, the extrem ely low concentration o f inactive renin both 
w ith in  human renal cortex and in human plasma (Sealey ^ . ,  1980) has, to  
date, prevented its  pu rifica tion  and detailed characterisa tion. I t  is therefo re  
not clear whether human inactive  renin is indeed a renin zymogen or whether i t  
is sim ply a prote in bound form  of the active  enzyme analogous to the form s of 
renin described in Section 1.3(a).
A t present, the best candidate fo r  a purified  renin zymogen is an 
inactive  renin of Mj. 50,000 isolated from  pig renin cortex (Inagami ^  a l., 
1982c; T ak ii and Inagami, 1982). The a c tiv ity  and size of th is protein were 
unaffected by agents known to dissociate protein complexes, such as SDS, urea, 
or guanidine hydrochloride. In contrast, i t  was fu lly  ac tiva ted  a fte r trea tm ent 
w ith  e ithe r plasmin or trypsin and a concom itant reduction in size to an Mj, 
value close to  tha t o f active  renin (38,000) was observed. I t  is highly like ly , 
though not yet proven, tha t th is protein corresponds to  the prorenin 
demonstrated during the jn  v itro  transla tion  o f mRNA coding fo r  renin (Section 
1.2).
1.4 The present study
The renin-angiotensin system plays a centra l ro le  in the regulation o f 
blood pressure and partic ipates in many form s o f hypertension. The possib ility  
tha t inactive  renin is a renin zymogen and tha t the ac tiva tion  o f inactive renin 
is a contro l point fo r the regulation o f c ircu la ting  renin a c t iv ity  is therefore o f
great in te res t. However, as discussed in the preceding section, l i t t le  is known 
about human inactive  renin at the m olecular level. Most attem pts to 
characterise th is fo rm  o f renin have involved studies o f its  properties in e ither 
whole or frac tiona ted  plasma, or in crude kidney extracts . The aim o f the 
present study was to  iso late small quantities of both active  renin and inactive  
renin from  human renal cortex in order to allow a more detailed s truc tu ra l 
characterisa tion o f the two form s o f the enzyme.
C H A PTER  2 
M A TE R IA LS  A N D  METHODS
2.1 M a te ria ls
(a) Biochemicals
A ll reagents were o f the best grade available com m ercia lly . W ith the 
exceptions o f the compounds listed below, the reagents were obtained from  
BDH Chemicals L td ., Poole, Dorset, U .K . Ammonium sulphate was 'AnalaR' 
grade ra the r than 'Enzyme' grade throughout.
Benzamidine hydrochloride, bovine serum albumin (Fraction V), 
Coomassie B r illia n t Blue G, haemoglobin (type I: bovine, crystallised),
haemoglobin (type II: bovine, substrate grade), g-Lactog lobu lin  B (from bovine 
m ilk), ovalbumin (e lec trophore tica lly  pure), phenylmethanesulphonyl fluo ride , 
polyoxyethylenesorbitan monolaurate (Tween 20), soybean trypsin inh ib ito r 
(SBTI), and N-succin im idyl-3-(4-hydroxyphenyl)propionate were obtained from  
Sigma (London) Chem ical Company L td ., Poole, Dorset, U .K .
Blue D extran and Dextran TIO were purchased from  Pharmacia (Great 
B rita in ) L td ., Hounslow, Middlesex.
Bovine serum albumin (e lectrophore tica lly  pure) was purchased from  
Boehringer Corporation (London) L td ., Lewes, Sussex, U .K .
Human serum albumin was obtained from  A.B. Kabi, Stockholm, Sweden.
(Ile^)-angiotensin I was obtained from  Schwartz Bioresearch, Orangeburg, 
New York.
(b) Reagents fo r  polyacrylam ide gel electrophoresis
Acry lam ide and N ,N '-m ethylene-b is-acrylam ide (specia lly purified fo r gel 
electrophoresis), ammonium persulphate, sodium dodecyl sulphate and N ,N ,N ',N ' 
te tram ethylenediam ine (TEMED) were 'AnalaR' grade reagents which were 
obtained from  BDH Chemicals L td ., Poole, Dorset, U .K .
(c) Enzymes
Aldolase (EC 4.1.2.13) from  rabb it muscle, carbonic anhydrase (EC 
4.2.1.1) from  bovine erythrocytes and pyruvate kinase (EC 2.7.1.40) from  
rabb it muscle were purchased from  Boehringer Corpora tion (London) L td ., 
Lewes, Sussex, U .K . Lysozyme (EC 3.2.1.17) from  chicken egg w h ite  
(e lec tropho re tica lly  pure) and trypsin  (EC 3.4.21,4) from  bovine pancreas (type 
III) were purchased from  Sigma (London) Chemical Company L td ., Poole, 
Dorset, U .K . V8 proteinase from  Staphylococcus aureus was obtained from  
Miles Laboratories L td ., Stoke Poges, Slough, U .K .
Pig renin (MRC reagent 65/119) and In te rna tiona l Reference Standard 
Human Renin (MRC reagent 68/356) were obtained from  the  National Ins titu te  
fo r  B io log ica l Standards and C ontro l, Hampstead, London, U .K .
Cathepsin D (3.4.23.5) from  human spleen was a g if t  from  D r A .J. 
B a rre tt, Strangeways Research Laboratory, Cambridge, U .K .
(d) Radiochem icals
(^H )acetic  anhydride (500m Ci/m m ole) and N-succin im idyl-3-(4-hydroxy, 
5»(125i)iocfophenyl)propionate (2000Ci/mmole) were purchased from  Amersham 
In te rna tiona l PLC, Bucks, U .K . ^^C -m ethyla ted proteins were obtained from  
New England Nuclear, Southampton, U .K ., and were as fo llow s:
^^C -m ethy la ted  bovine serum albumin (0.017m Ci/m g)
^^C -m ethy la ted  ovalbumin (0.012mCi/mg)
^^C -m ethy la ted  carbonic anhydrase (O .O llm C i/m g)
(l^^I)ang io tens in  I (c irca  500mCi/mg) was prepared in the Blood 
Pressure U n it Laboratories by Mrs M. Hughes. The radio iodination of 
angiotensin I and the pu rifica tion  of the labelled peptide were carried out as 
described by M orton et ^ . ,  (1976).
(e) Chrom atographic m ateria ls
Octyl-Sepharose CL-4B, Sephadex G50 (medium grade) and Sephadex
GlOO (superfine grade) were obtained from  Pharmacia Fine Chemicals, 
Uppsala, Sweden. A c tiva ted  6-aminohexanoic acid Sepharose 4B (Cat. No. 
A9019) and cyanogen bromide activated-Sepharose 48 were obtained from  
Sigma (London) Chem ical Co. L td ., Poole, Dorset, U .K .
(f) Miscellaneous m ateria ls
S c in tilla to r 299 was obtained from  Packard-Becker BV Chemical 
Operations, The Netherlands. The peptide H.77 was k ind ly  supplied by Dr M. 
Szelke, Departm ent o f Chemical Pathology, Royal Postgraduate Medical 
School, Ham m ersm ith Hospita l, London. F15 monoclonal antibody was kind ly 
supplied by D r B. Pau, Centre de Recherches C lin -M idy , M ontpe llie r, France. 
Human kidneys were obtained from  individuals examined post mortem in the 
Departm ent o f Pathology, Western In firm a ry , Glasgow.
2.2 G e ne ra l m ethods
(a) Glassware
A ll item s of glassware were washed in solutions o f the detergent Decon 
75 (Decon Laboratories L td ., Hove, U .K .), rinsed thoroughly w ith  tap w ater, 
then d is tille d  w ater, and dried in an oven at 60°C. For amino acid analysis, 
glassware was add itiona lly  trea ted  by immersion in concentrated n itr ic  acid 
fo r  Ih  fo llow ed by d is tilled  w ater fo r  Ih . P ipettes were soaked in 2% (v/v) 
Decon 75 fo r 10 days and were thoroughly rinsed using an autom atic p ipette 
washer. F ina lly , the p ipettes were rinsed w ith  d is tille d  w ater and dried in 
an oven at 60°C.
(b) M ic rop ipe ttinq
Solution volumes in the range 10p i to  1ml were transfe rred  reproducibly 
using e ithe r 'P ipetman D ig ita l P ipettes' (Anachem L td ., Luton, U.K.) or 
adjustable 'F innpipettes' (Jencons (S c ien tific ) L td ., Leighton Buzzard, 
Bedfordshire, U .K .). Volumes in the range 0 .5p i to 50p i were transferred 
accurate ly using e ithe r a SMI D ig ita l Adjust M ic ro /P e tto r (Alpha Laboratories,
Eastleigh, Hampshire, U .K .), or m icrosyringes.
(c) pH measurement
Measurements o f pH were carried out using an E lcom atic  Instruments 
L td ., model 7065 d ig ita l pH m eter f it te d  w ith  a com bination electrode
(Gallenkamp & Co. L td ., East K ilb ride , Glasgow, U .K .). This apparatus was 
standardised regu larly  using solutions o f pH 7.0 and pH 4.0 prepared using 
bu ffe r tab le ts  (BDH Chemicals L td ., Poole, Dorset, U .K .).
(d) C en trifuga tion
P reparative cen trifuga tion  was rou tine ly  perform ed at 4®C. 
A cce lerations o f up to  lOOOg were obtained using a 'Centra-7R* benchtop
cen trifuge  (Damon/IEC (U .K.) L td ., Dunstable, Beds,, U .K .). Accelerations of 
up to 100,000g were obtained using a Beckman L2-65B cen trifuge  f it te d  w ith  
a titan iu m  T i-60 ro to r (Beckman RIIC L td ., G lenrothes, F ife , U .K .).
(e) D ia lysis and u ltra f ilt ra t io n
The dialysis o f samples was carried out using Visking Tubing (S c ien tific  
Instrum ent Centre L td ., 1 Leeke S treet, London) which had been immersed in 
boiling Im M -EDTA, pH 7.0 fo r  15 m inutes and then washed in d is tilled  w ater. 
Sample volumes of less tha t 500pi were dialysed using Schleicher & Schull 
type UH 100/10 U ltra  Thimbles (Anderman & Co. L td ., East Molesey, Surrey, 
U .K.). The U ltra  Thimbles were sealed using small glass stoppers in order to
m inim ise the increase in sample volume during dialysis.
The concentration of prote in samples was carried out by u ltra f ilt ra t io n  
using a vacuum dialysis apparatus (Schleicher &  Schull) f i t te d  w ith  a type UH 
100/10 u ltra  th im ble .
(f) Measurement of prote in concentration
P ro te in  concentration was measured using the dye-binding method 
o f B radford (1976) as m odified by M acart & Gerbaut (1982).
Dye reagent Coomassie B r illia n t Blue G (lOOmg) and SDS
(30mg) were dissolved in 50ml o f 95% (w /v) ethanol. 85% (w /v) phosphoric 
acid (100ml) was added to this solution and the m ixture  was then diluted to a 
f in a l volume o f 1 l it re .
1ml o f the dye reagent was added to 50p i o f each sample to be 
assayed. The absorbance at 595nm was measured a fte r  15 m in against a 
reagent blank prepared from  50p i o f the appropriate b u ffe r and 1ml of the 
dye reagent. Standard curves were prepared from  protein solutions
containing 0,5pg to  lO pg of bovine serum albumin in 50p l o f 50mM-sodium 
phosphate, pH 7.0.
(g) D is tille d  w ater
Glass d is tilled  w ater stored in e ither glass or polythene containers was 
used in a ll experiments,
2.3 P reparation  of chrom atographic media
(a) Sephadex Gels
Sephadex gels were swollen and poured according to  the manufacturer's
instructions and were stored at in 0.02% (w /v) sodium azide.
(b) H.77-5epharose
H.77 was coupled to  Sepharose through the N -te rm in a l amino group by 
reaction w ith  the N-hydroxysuccinim ide ester o f 6-aminohexanoic acid- 
Sepharose 4B (activa ted  6-aminohexanoic acid - Sepharose 48). A ctiva ted  
Sepharose (lOg) was swollen and washed at room tem pera ture w ith  2 litres  o f
Im M -H C l on a sintered-glass funnel. H.77 (100mg) was dissolved in 30ml o f
O .lM -NaHCO ^ (pH 8.Q)/0.5M-NaCl (coupling bu ffe r) and m ixed w ith  the washed 
gel. The gel suspension was gently shaken fo r  16h at 4°C , a fte r which 
excess ligand was washed from  the gel w ith  coupling bu ffe r (500ml). The 
rem aining reactive  groups were blocked by trea tm ent of the gel in lOOmI o f 
IM -e thano lam ine /H C l, pH 9.0, fo r  Ih  at 2 0 °C . The H.77-Sepharose was 
washed w ith  f ive  cycles o f coupling bu ffe r (200ml) fo llow ed by O.lM-sodium
acetate (pH 4.0)/0,5M -NaC l (200ml) and fin a lly  equ ilib ra ted w ith  50mM- 
T ris /H C l, pH 7.4.
The amount o f peptide coupled to  the gel was determ ined by amino 
acid analysis a fte r hydrolysis of 0.5ml o f H.77-Sepharose in 2ml o f 6N-HC1 fo r 
20h at 110°C. 0.5 y moles o f DL-norleucine was included in the hydrolysis
m ix tu re  as an in te rna l standard. Analysis o f the hydrolysate was carried out 
using a model 4400 amino acid analyser (LKB Instrum ents L td ., S. Croydon, 
Surrey), and the peptide content was calculated from  the recovery o f 
phenylalanine, 0.9 y moles o f H.77 were coupled per m l o f gel.
(c) F15-Sepharose
F15 monoclonal antibody was coupled to Sepharose by reaction w ith  
cyanogen bromide activa ted  Sepharose 4B. A c tiva ted  Sepharose (Ig) was 
swollen and washed at room tem perature w ith  200ml o f Im M -H C l on a 
sin tered glass funnel. F15 monoclonal antibody (12mg) dissolved in 6ml o f 
0.2M-NaHCO3 (pH 8.5)/0.5M -NaC l (coupling bu ffe r) was m ixed w ith  the washed 
gel and the gel suspension was then gently shaken fo r 20h at 4°C. The 
rem aining reactive  groups were blocked by trea tm en t of the gel w ith  20ml of 
IM -e thano lam ine /H C l, pH 9.0 fo r Ih  at 20°C. The F15-Sepharose was then 
washed w ith  f ive  cycles o f coupling bu ffe r (20ml) fo llow ed by 0.2M-sodium 
acetate (pH 4.0)/0.5M -NaC l (20ml) and fin a lly  equ ilibrated w ith  50mM-sodium 
phosphate, pH 7.4.
2.4 Enzym e assays
(a) Renin
Renin concentration was measured using the method of M illa r ^  a l., 
(1980). This method is based on the radioimmunoassay o f the angiotensin I 
generated during the incubation of renin w ith  excess ox renin substrate.
The fo llow ing  stock reagents were prepared;
B u ffe r A ; 3M -T ris /H C l (pH 6.9)/0.2M-EDTA
Jb
B u ffe r B: 50m M -Tris/H C l (pH 7.4)/5m M -EDTA/0.5%  (w /v)
bovine serum albumin (Fraction V)
D extran coated charcoal; 6.3g o f charcoal and 0.125g
of Dextran T70 were suspended in 100ml o f
bu ffe r B.
Assays were carried out by incubating 35 y l o f enzyme solution at 37°C 
w ith  55y 1 o f a pre-m ixed solution consisting o f ox renin substrate (see Section
2.5), bu ffe r A , and antiserum to angiotensin I d ilu ted in bu ffe r B (1:68 v/v).
The ra tio  o f the pre-m ixed components was 8:2:1 by volume. The enzyme 
reaction  was term inated by adding 1,4ml o f ice-co ld b u ffe r B. lOpg (5,000- 
I0,000cpm ) o f (^^^Dangiotensin I in 50 y 1 o f bu ffe r B was added to the
m ix tu re  and the radioimmunoassay was completed by fu rth e r incubation at 4°C 
fo r 48h. The separation o f free  and bound ligand was achieved by adding 
150 y 1 o f Dextran coated charcoal, and im m ediate ly cen trifug ing  the m ixture  
fo r 10 m in at l,000g  and 4°C . The supernatant solution was removed by 
suction and the (^^^Dangiotensin I adsorbed to the charcoal pe lle t was then 
measured using a model NE 1612 gamma counter (Nuclear Enterprises L td ., 
S igh th ill, Edinburgh, U .K .).
Standard curves fo r angiotensin I were prepared by seria l d ilu tion o f 
(He ^) angiotensin I in 35 y 1 o f 7% (w /v) human serum albumin from  lOOOpg to  
8pg angiotensin I per tube in duplicate. Tubes containing no angiotensin I 
were also included. 55y 1 o f the pre-m ixed substrate solution was added to
each tube and the standards were then trea ted in an iden tica l manner to  the 
unknown assay samples.
For each enzyme sample the ve loc ity  o f angiotensin I generation was 
determ ined using one tim ed incubation in duplicate and a zero tim e 
measurement. The assay results were expressed in In te rna tiona l Units o f 
renin by comparison w ith  the In te rna tiona l Reference Standard Preparation o f
Human Renin (MRC reagent 68/356). One unit o f renin generated angiotensin 
I a t a ra te  o f 182.8yg /h  in the above assay system (Figure 2.1).
(b) Inactive  renin
Inactive  renin was assayed by measuring the increase in renin a c tiv ity  
produced by the trea tm en t o f samples w ith  trypsin . The activa tion  o f 
inactive  renin was carried out using a m od ifica tion  o f the method described 
by A tlas  e t (1980). The fo llow ing  stock solutions were prepared:
B u ffe r A ; 50m M -Tris /H C l (pH 7.4) /20m M -benzam idine/
5m M -E D TA /l%  (w /v) bovine serum albumin 
(F raction V).
Trypsin solution; C rysta lline  trypsin (12,000 BAEE units/m g
see Section 2.4(d)) was dissolved in Im M -H C l to 
a fin a l concentration o f Im g /m l. Fresh
solutions o f the enzyme were prepared each 
day. The crysta lline  enzyme was stored at
-20°C in a .lesiccxuror. Under these conditions, 
no loss in the a c tiv ity  o f the enzyme was 
observed over a period o f 2 years,
SBTI solution: Soybean trypsin inh ib ito r was dissolved
in 50m M -Tris/H C l, pH 7.4 to  a fina l 
concentration o f 2m g/m l.
50 y 1 o f each sample was added to  450 y 1 o f B u ffe r A . 50 y l o f trypsin 
solution was added and the solution was incubated fo r 5h at 4°C. The 
reaction was stopped by adding 50 y 1 of SBTI solution and the renin 
concentration was then measured as described in Section 2.4(a). Zero tim e  
samples were included in the renin assay to  a llow  fo r  angiotensin I 
im m unoreactive m a te ria l generated during the incubation of unknown samples 
w ith  trypsin .
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Figure 2.1 Renin assay ca lib ration  curve
D ilu tions o f the In te rna tiona l Reference Standard Preparation o f Human Renin 
(MRC reagent 68/356) in 50m M -Tris/HC l (pH 7.4)/5m M -EDTA/0.5%  (w/v) bovine 
serum albumin were assayed as described in Section 2.4(a) and the velocity of 
angiotensin I generation (expressed as pg angiotensin I/h r/tu b e ) was plotted 
against^enzyme concentration Each point is the mean o f five  measurements. 
cIvL d-ie. so rtpk ..
The renin concentration measured a fte r tryps in -ac tiva tion  was defined 
as the to ta l renin concentration. The active  renin concentration was 
measured a fte r  an identica l incubation at 4°C except tha t the trypsin solution 
was replaced w ith  Im M -H C l. The inactive  renin concentration was
calcu la ted as the d iffe rence between the to ta l renin concentration and the 
active  renin concentration.
(c) A c id  proteinase
A cid  proteinase a c t iv ity  was assayed by measuring the release of ^H - 
labelled peptides from  (^H)acetylhaemoglobin. The labelled substrate (35x10^ 
dpm/mg) was prepared as described by H ille  et (1970). C rysta lline 
haemoglobin (650mg) was reacted w ith  0.05mmoles of (^H )acetic anhydride 
(500m Ci/m m ole) in 3.5ml of O.GlM-sodium phosphate, pH 7.5, fo r  Ih  at 4°C . 
The product was purified  by chromatography on a column (1.6cm x 26cm) of 
Sephadex G50 equ ilib ra ted  w ith  the same bu ffe r. The labelled haemoglobin
l O O m l .
was p rec ip ita ted  by adding 3%(w/v) tr ich lo roa ce tic  acid, resuspended in O .lM - 
sodium te trabo ra te , and then dialysed against O.OlM-sodlum te traborate 
fo llow ed by O.GlM-sodium phosphate, pH 7.4. The purified
(^H)acetylhaemoglobin was stored at -2G°C at a concentration o f 20mg/mL
Assays were carried out by incubating 10p i o f enzyme solution fo r Ih  
at 37°C w ith  50p i o f IM -sodium  fo rm ate , pH 3.3 and 40p i o f a substrate 
solution prepared by dissolving 87mg of (^H)acetylhaemoglobin and Ig  of 
unlabelled haemoglobin in w a ter to  a fin a l volume of 20ml, The reaction 
was te rm inated by adding 0.5ml o f 3% (w /v) tr icho roace tic  acid and
prec ip ita ted  pro te in  was removed by cen trifuga tion  at lOOOg and 4°C fo r 
30min. A 0.2m l sample of the supernatant solution was then removed fo r  
liqu id  s c in tilla tio n  counting in 8ml of Packard s c in tilla to r  299. Assay blanks 
were prepared by delaying the addition o f the enzyme solution un til a fte r the 
in troduction  o f the trich lo ro a ce tic  acid.
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F ig u re  2 .2 . Standard curve fo r acid proteinase assay
D ilu tions o f pure human spleen cathepsin D In lOmM-sodium phosphate (pH 
7,0)/0.005% (w /v) bovine serum albumin v/ere assayed by measuring the release 
o f ^H-iabelied peptides from  (^H )acetyi haemoglobin as described In Section 
2.4(c) and the results (expressed as cpm/assay) were p lo tted  against enzyme 
concentration.
The assay results were expressed in units o f enzyme a c tiv ity  by 
comparison w ith  human spleen cathepsin D (Figure 2.2). One unit o f a c tiv ity  
was defined as the a c t iv ity  exhib ited by Ip g  of pure human spleen cathepsin 
D in the above assay system.
(d) Trypsin
Trypsin a c t iv ity  was measured using the method of Schwert & Takenaka 
(1955). Samples (200p i) o f trypsin dissolved in Im M -H C l were incubated at 
25°C w ith  2.8ml o f a substrate solution consisting o f N -benzoyl-L-arg in ine 
e thyl ester (0,96nM) in 50mM T ris /H C l (pH 8.0)/20mM C aC l2 . The 
production o f N -benzoyl-L-arg in ine was m onitored spectrophotom etrica lly at 
253nm using cells w ith  a 1cm lig h t path. One BAEE un it o f trypsin a c t iv ity  
was defined as the a c t iv ity  required to  produce an increase in extinction  at 
253nm o f O.GOl/min under the above conditions.
2.5 P reparation  o f ox renin substrate
Renin substrate was p a rtia lly  purified from  the plasma of b i- 
nephrectomised oxen by ammonium sulphate frac tiona tion .
Whole blood (39 litre s ) was co llected from  three bi-nephrectomised oxen 
one week a fte r nephrectomy, using EOT A (5mM) as anticoagulant, and was 
centrifuged fo r 30 m in at lOOOg and 4°C. The plasma obtained (18 litre s ) 
was made 1.4M w ith  respect to  ammonium sulphate by adding 205-6g o f 
crushed ammonium sulphate per l i t r e  o f plasma over a period o f 30 min w ith  
constant s tir r in g . The solution obtained was allowed to  stand overnight a t 
4°C and then prec ip ita ted  prote in was removed by cen trifuga tion  fo r 30 m in 
at lOOOg and 4°C . The supernatant solution (15.9 litre s )  was adjusted to  
3.0M w ith  respect to  ammonium sulphate by adding a fu rth e r 270.7g of 
crushed ammonium sulphate per l i t r e  o f solution over a period o f 60 m in. 
The solution was s tirred  overnight at 4^C and then prec ip ita ted  protein was 
co llected by cen trifuga tion  fo r  90 m in at lOOOg and 4°C . The precip ita te
was dissolved in 3 litre s  of d is tilled  w ater and was then dialysed exhaustively 
against 50mM-sodium phosphate, pH 6.9, The p a rtia lly  purified  ox renin 
substrate obtained a fte r  dialysis (9 litre s ) was aliquoted in to  500ml portions 
and was stored frozen at -20°C .
The concentration o f angiotensinogen in the frac tiona ted  ox plasma was 
measured by radioimmunoassay o f the angiotensin I produced a fte r exhaustive 
incubation w ith  pig renin. This was carried out using a m od ifica tion  o f the 
renin assay method described in Section 2.4(a). Samples (40p i) of the 
substrate solution d ilu ted in 7% (w /v) human serum albumin were incubated a t 
37°C w ith  1 unit o f pig renin (MRC reagent 65/119) dissolved in 35 p i of 
50mM - T ris /H C l (pH 7.4)/0.5% (w /v) bovine serum albumin (F raction V) and 
15 p i of a pre-m ixed solution consisting of bu ffe r A and antiserum to 
angiotensin I d ilu ted in bu ffe r B (1:68 v/v). The ra tio  o f the pre-m ixed 
components was 2:1 by volume. The enzyme reaction was term inated by 
adding 1,4ml o f ice-co ld  bu ffe r B and the radioimmunoassay o f angiotensin I 
was completed as previously described in Section 2.4(a). Standard curves fo r  
angiotensin I were prepared by seria l d ilu tion  of (Ile^) angiotensin I in 35p i of 
7% (w /v) human serum albumin from  lOOOpg to 8pg angiotensin I per tube in 
dup licate . Tubes containing no angiotensin I were also included. 40p l o f 
7% (w /v) human serum albumin and 15p i o f  the pre-m ixed antibody solution 
were added to  each tube and the standards were then trea ted  in an identica l 
manner to  the unknown assay samples.
Under the above conditions, the amount of angiotensin I released from  
ox angiotensinogen reached a plateau a fte r Bh, corresponding to  4.2 pg 
angiotensin I released per m l o f stock substrate solution.
2.6 Po lyacry lam ide gel electrophoresis
(a) SDS/polyacrylam ide gel electrophoresis
E lectrophoresis in the presence o f 0.1% (w /v) SDS was carried out using
the discontinuous system described by Laem m li (1970).
The fo llow ing  stock solutions were prepared:
Solution A: 30% (w /v) acrylamide/O.0% (w /v) bisacrylamide
(stored at 4°C).
Solution B: l,5 M -T ris /H C l, pH 6.8 (stored at 4°C).
Solution C: 1 .5M -Tris /H C l, pH 8.8 (stored at 4°C).
Solution D; 10% (w /v) SDS.
Solution E: 1.5% (w /v) ammonium persulphate (fresh ly prepared 
before use).
Reservoir bu ffe r: 0.025M -Tris/0.192M -glycine (pH 8.3)/0.1%
(w /v) SDS.
Sample bu ffe r: 72.5m M -Tris/HC l (pH 6.8)/3% (w /v) SDS/10%
(v/v) g lycero l/5%  (v/v) 2-mercaptoethanol/0.002%  (w /v) 
bromophenol blue.
The gel m ixtures were prepared using the volumes indicated in Table 
2.1. In each, case, the gel m ix tu re , except fo r  TEMED, was prepared at 4°C 
in a sm all flask and degassed fo r  2 m in using a w ater suction pump.
Polym erisation was in itia te d  im m ediate ly before pouring the gel by adding the 
co rrec t volume of TEMED to  the m ixtu re .
Slab gels were cast between glass plates separated by 1mm spacers. 
The resolving gel m ix tu re  was poured between the glass plates leaving
s u ffic ie n t space fo r  a stacking gel to be poured la te r. Gel buffer o f the 
same composition as in the resolving gel was then gently layered onto the gel 
surface. A fte r  polym erisation was complete the overlay was removed and 
the resolving gel surface was rinsed w ith  a sm all volume o f stacking gel 
m ix tu re . This was discarded and the remaining space between the glass 
plates was fille d  w ith  the stacking gel m ixtu re . A comb fo r  form ing sample 
wells was im m edia te ly inserted in to the gel m ix tu re  and the stacking gel was
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Table 2.1
Recipe fo r gel preparation using the SDS-discontinuous 
b u ffe r system of Laem m li (1970)
Stock solution F ina l acrylam ide concentration (%F 
Stacking gel Resolving gel
3 10 12.5
Solution A 3 .0 10.0 12.5
Solution B 2.5 - -
Solution C -  ■ 7 .5 7.5
Solution D 0 .3 0.3 0-3.
Solution E 1.0 1.0 1.0
W ater 23.2 11.2 8-7
TEMED 0.015 0.015 0-015
® The columns represent volumes (m l) o f the various reagents 
required to make 30ml o f gel m ix tu re .
4 3
allowed to set. The comb was then ca re fu lly  removed and the sample wells 
were rinsed w ith  and then f il le d  w ith  reservoir bu ffe r.
P ro te in  samples were m ixed w ith  an equal volume o f sample bu ffe r and 
were heated to 100°C in a boiling w ater bath fo r 3 m in. A f te r  the samples 
had cooled, they were ca re fu lly  layered in to  each sample w e ll of the gel. 
E lectrophoresis was carried out at constant voltage (50V) u n til the tracking 
dye had trave lle d  the length o f the gel. The gel was then fixed  and stained 
fo r  pro te in  as described in Section 2.6(b).
Rod gels were cast in glass tubes (5mm in te rna l d iam eter). The gels
were prepared in an identica l manner to the slab gels except tha t the 
stacking gel solution was overlayered w ith  stacking gel buffer before 
polym erisation was complete. A fte r  the gel had set the surface of the
stacking gel was rinsed w ith  reservoir bu ffe r. P rote in  samples were prepared 
as described above and care fu lly  layered onto the surface o f each gel. 
E lectrophoresis was carried out at 2mA per gel.
(b) D e tection  of protein bands in polyacrylam ide gels.
Staining w ith  Coomassie B r illia n t Blue
Proteins were fixed  in polyacrylam ide gels by soaking the gels in 
12.5% (w /v) tr ich lo ro a ce tic  acid fo r 30 m in at room tem pera ture . Each gel 
was then stained by immersion in a 0.1% (w /v) solution o f Coomassie B r illia n t 
Blue in m ethano l/ace tic  ac id /w ate r (5 /1 /4 by volume) fo r 2h at 40°C. 
Excess stain was removed by soaking the gel in m ethano l/ace tic  acid /w ater
(1/1 /8 by volume) a t 40°C u n til a clear gel background was obtained.
S ilver staining
The s ilve r staining o f proteins in polyacrylam ide gels was carried 
out essentia lly as described by Wray et (1981). S ilver sta in and developer 
solutions were prepared im m edia te ly before use as fo llow s;
Stain solution; 2.8ml o f 14.8M-NH^GH was added to 42ml
45
of 0.36% (w /v) NaOH. S ilver n itra te  (1.6g) 
dissolved in 10ml of w ater was added dropwise 
to  th is m ix ture  and the solution was made to  a 
f in a l volume o f 200ml w ith  w ater.
Developer solution; 2.5ml o f 1% (w /v) c it r ic  acid and
0.25ml o f 38% (w /v) formaldehyde solution
were mixed and made to  a fin a l volume of 
500ml w ith  water.
Proteins were fixed  in polyacrylam ide gels by im mersion o f the gels in
m ethanol/acetic  ac id /w ate r (5 /1 /4  by volume) fo r Ih  at 37°C. Each gel was
then soaked at room tem perature in 50% (v/v) methanol fo r 24h w ith  four 
changes o f methanol. Prote in staining was carried out by soaking the gels in 
stain solution fo r  20 min w ith  constant gentle ag ita tion . The gels were 
washed in w a ter fo r 5min and then transferred to developer solution un til the 
prote in bands appeared. The stain development was stopped by immersion o f 
the gels in 10% (v /v) ace tic  acid. The stained gels were rinsed in w ater and 
were stored in 50% (v /v) methanol in the dark.
D e tection  o f radio labelled proteins
Polyacrylam ide slab gels containing proteins labelled w ith  were
in it ia lly  fixed  and stained w ith  Coomassie B r illia n t Blue as described above.
The stained gels were soaked overnight in 10% (v /v) methanol/3% (v/v) 
g lycero l and were then dried down onto Whatman 3MM f i l t e r  paper using a 
model 224 gel dryer (Bio-Rod Laboratories, 2200 W right Avenue, Richmond, 
C a lifo rn ia , 94804, U.S.A). The radio labelled proteins were then detected by 
ind irec t autoradiography o f the dried gel using Kodak X -O m at AR5 f ilm  w ith  
an X -ray  in tens ify ing  screen (Antony Monk (Eng) L td ., Sutton in Ashfie ld, 
U .K .)
2,7 D e te rm in a tio n  of re la tiv e  m olecular mass (Mp)
The Mp values o f active  renin and inactive renin were estimated both 
by gel f i l t ra t io n  chromatography and by electrophoresis in the presence o f 
0.1% (w /v) SDS.
(a) Mp estim ation by gel f i l t ra t io n  chromatography
Gel f i lt ra t io n  chromatography o f a ll samples was carried out at 4°C . 
A column (1.6 cm x 65 cm) o f Sephadex GlOO (superfine grade) was packed 
and equ ilib ra ted in 50m M -Tris/H C l (pH 7.4)/20mM-benzamidine/5mM 
EDTA/0.01%  (w /v) lysozyme (e lution bu ffe r). Samples (1-5 m illiun its ) o f the 
pu rified  enzymes dissolved in 1ml o f e lution bu ffe r containing 3% (w /v) 
g lycero l were applied to the column and run through at a flow  ra te  o f 2m l/h. 
Fractions o f 1ml were collected and assayed fo r active  or inactive renin as 
described in section 2.4. ^'^C-m ethylated m arker proteins (0.5 uC i each) were 
included in each sample as in terna l standards. F ractions were assayed fo r 
by liqu id s c in tilla tio n  counting o f 0.2ml o f each frac tio n  in 8ml o f 
Packard s c in tilla to r  299.
Mp values were determ ined by comparison w ith  standard curves o f Kgy, 
defined as:
e lu tion volume (Vg) - void volume (Vq) 
to ta l volume (V^) -  void volume (V^) 
versus log Mp. Vq was determ ined by measuring the e lu tion volume o f a 
1ml sample (2m g/m l) o f Blue Dextran. The ^^C -m ethy la ted  marker proteins 
used were ^^C -m ethy la ted  bovine serum albumin, ^^C -m ethy la ted  ovalbumin 
and ^^C -m ethy la ted  carbonic anhydrase. In p re lim inary  experiments, these 
labelled proteins were found to co-e lu te w ith  unlabelled bovine serum albumin, 
ovalbumin and carbonic anhydrase respective ly. The ir Mp values are given in 
Table 2.2.
(b) M r estim ation by electrophoresis in the presence o f 0.1% (w /v) SDS.
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Polyacrylam ide gel electrophoresis o f proteins was carried out using the 
gel system of Laem m li (1970). Unknown Mp values were determined by 
comparison w ith  standard curves o f e lectrophoretic  m o b ility  versus log Mp. 
For slab gels, e lectrophore tic  m ob ility  was defined as the distance m igrated 
by the prote in . In the case o f rod gels, e lectrophore tic  m o b ility  was defined 
as:
distance m igrated by prote in 
distance m igrated by tracking dye.
The Mp values o f the standard marker proteins are given in Table 2.2.
Table 2.2
Subunit M f values of standard proteins
Prote in Subunit Mp value Reference
Bovine serum albumin 66,200 Peters (1975)
Pyruvate kinase 57,000 Steinm etz and Deal (1966)
Ovalbumin 43,000 Castellino and Barker (1968)
Aldolase 40,000 Kawahara and Tan ford (1966)
Carbonic anhydrase 29,000 Lambin (1978)
Soybean trypsin  inh ib ito r 20,100 Lambin (1978)
B-LactoglobuUn B 17,500 R igha tti and Caravaggio (1978)
Lysozyme 14,300 Lambin (1978)
D U  .
C H A P TE R  3 
TH E R E N IN  C O N TE N T OF AUTO PSY K ID N E Y S
3.1 In troduction
In spite o f its  im portance, renin has been pu rified  to  homogeneity only 
w ith in  the last decade. One problem encountered in its  pu rifica tion  has been 
the low concentration o f the enzyme in the renal co rtex (Inagami et 1977b; 
S later, 1980). In pa rticu la r, 'norm al' human renal cortex, which can only be 
obtained post m ortem , has been reported to contain particu la rly  low 
concentrations o f the enzyme (Inagami e t aL, 1977b), Published procedures fo r  
the p u rifica tio n  o f human renin, using several kilogram s o f renal cortex as 
s ta rtin g  m a te ria l have yielded only a few hundred m icro grams of pure enzyme 
(Slater e t 1978; Yokosawa et aL, 1978; Yokosawa e t 1980; Higaki ^  a l., 
1983).
The renin content o f human kidneys obtained post m ortem  m ight be 
expected to  vary considerably, depending both on the physiological status o f the 
ind iv idual a t the tim e  o f death, and on the delay between death and the 
rem oval o f the kidney at autopsy. In the present study, therefore , pre lim inary 
experiments were carried out to determ ine the quantities o f renin present in the 
renal cortex o f individual human kidneys and only tissue containing re la tive ly  
high concentrations o f both active  renin and inactive  renin was selected fo r use 
in subsequent pu rifica tion  studies.
3.2 M easurem ent o f renin content o f autopsy kidneys
(a) P reparation o f extracts o f renal cortex
Eleven human kidneys were obtained post m ortem  from  individuals w ith  
no h is to ry  o f renal disease. In each case a Ig  sample o f renal cortex was 
removed from  the kidney and the remainder o f the kidney was stored frozen at 
-20°C . Each sample of cortex was homogenised in 5ml o f 50mM-Tris/MCl
b i .
(pH 7.4)/20m M -benzam idine/5m M -EDTA/lm M -phenylm ethanesulphonyl 
fiuo ride /0 .5m M -N -e thy l maleim ide/O.Gl% (w /v) Tween 20 (extraction  buffer) w ith  
a Po iytron  PT 20s (5 m in, 25,000 rev/m in ) and the homogenates were
centrifuged fo r  30 m in at 100,000g and 4°C. Each pe lle t was washed w ith  a 
fu rth e r 5ml o f ex trac tion  bu ffe r, centrifuged as described above and the wash 
was then added to  the in it ia l supernatant.
(b) Assay o f active  renin and of inactive  renin in extracts  
The concentrations o f active  renin and of inactive  renin present in the 
extracts o f renal co rtex were measured using the methods described in Section 
2.4. For each ex tra c t, six measurements of the ac tive  renin concentration 
and o f the to ta l renin concentration (defined as the renin concentration 
measured a fte r tryps in -ac tiva tion ) were made, and the mean values were 
determ ined in each case. The inactive  renin concentration was calculated as 
the d iffe rence  between these means
3.3 R e s u lts  and d iscussion
The concentrations o f active renin and of inactive  renin in the individual 
ex trac ts  of renal cortex (expressed as m illiu n its /g  cortex) are given in Table 3.1. 
The concentrations o f both form s of the enzyme were found to  vary 
considerably. The range of active  renin concentrations was 7 to  3,400 
m illiu n its /g  cortex. Inactive  renin was present in a number o f kidneys, 
representing up to  25% o f the to ta l renin present in the renal cortex.
The concentration of inactive  renin was derived as a d iffe rence 
measurement between 'to ta l’ and 'ac tive ' renin. In cases where active renin 
form ed a large percentage (over 92%) o f the to ta l renin concentration, the 
values obtained fo r th is d iffe rence measurement were not s ta tis tic a lly  
s ign ifican t. The problems associated w ith  the measurement o f inactive renin 
in such situations have been discussed by several authors (M illa r et 1978; 
Sealey et a l., 1980; Derkx et a l., 1983) and in these cases i t  may be appropriate
5 2 .
to  assay inactive  renin a fte r  i t  has been chrom atographically separated from  the 
ac tive  fo rm  o f the enzyme. However, in the present study, in which inactive  
renin measurements were required only as a guide to  tissue levels o f the 
prote in , such a separation was considered unnecessary.
The studies described in Chapters 4 and 5 o f th is thesis were carried out 
using renal co rtex  obtained from  kidney no. 1 in . Table 3.1 (active renin 
concentration, 3.4 units/g; inactive  renin concentration, 1.1 units/g).
Table 3-1
Concentrations o f ac tive  renin and o f inactive  renin In 
extracts  of renal cortex prepared from  autopsy kidneys.
Renin concentration (m illiun its /g  cortex) 
Kidney A c tiv e ^ T o ta l^  Inac tive^
1 3400 + 150 4510 170 1110 *
2 2120 + 90 2330 + 110 210 *
3 1210 + 60 1250 + 80 40
4 404 + 18 429 ± 35 25
5 134 + 9 185 + 13 51 *
6 102 + 5 111 + 5 9
7 62.5 + 3 .1 70.9 ± 5.9 8 .4  *
8 32.9 + 2.1 34.6 + 6 .2 1.7
9 22.5 + 1.9 26.2 + 3.1 3 .7  *
10 11.7 + 0.9 12.9 ± 1.6 1.2
11 7.3 + 0 .3 9 .2 + 0.8 1.9  *
^ A c tive  renin and to ta l renin (renin concentration measured a fte r 
try psin -activa tion) were assayed as described in Section 2.4. Mean 
+ SD o f six measurements.
^ Inactive  renin was calculated as the difference between the 
mean values obtained fo r the to ta l renin concentration and the 
ac tive  renin concentration. * ,  p <0.05 (unpaired t-te s t).
C H A PTER  4
P U R IF IC A T IO N  OF R E N IN  FRO M  H U M A N  R E N A L C O R TE X .
4.1 In troduction
A ttem p ts  to  pu rify  renin over the last 40 years have largely re flec ted  
the s ta te -o f- th e -a rt in protein chem istry o f given periods. Early  studies, using 
conventional techniques such as salt and solvent frac tio na tion , gel f iltra tio n  and 
ion exchange chromatography yielded products which were markedly 
heterogeneous and which were o ften  unstable due to  the presence o f 
contam inating proteinases (Haas et 1953; M aier and Morgan 1966; Wauldhausl 
e t a l., 1970). In recent years, the application o f a f f in ity  chromatography to  th is  
problem has resulted in the isolation o f renin from  the renal cortex o f various 
species, including man (Inagami ^  ^ . ,  1980).
One problem encountered in the use of a f f in ity  chromatography in renin 
pu rifica tion  has been the lack o f a ligand which is both specific  fo r renin and 
binds the enzyme w ith  su ffic ie n t a f f in ity  to  sequester i t  from  crude extracts o f 
renal cortex. A ttem p ts  to use short peptide analogues o f renin substrate as 
ligands have produced adsorbents w ith  only moderate a ffin itie s  fo r renin 
(M ajstoravich e t ^ . ,  1974; Poulsen et ^ . ,  1975). The acyl at ed pentapeptide 
pepstatin has been used w ith  considerable success in the purifica tion  o f renin 
from  renal cortex (Murakami ^  aL, 1973; Devaux e t aU, 1976; Inagami e t aL, 
1980). U n fo rtuna te ly , however, i t  lacks sp e c ific ity , acting  as an excellent 
a f f in ity  ligand fo r  another tissue proteinase, cathepsin D . The purifica tion  o f 
renin using published protocols, there fo re , remains a lengthy procedure, involving 
several steps o f conventional chromatography as w e ll as a f f in ity  chromatography 
(Slater, 1981).
In the present study, a new potent peptide in h ib ito r o f renin, H.77 (D- 
H is-P ro -P he-H is-Leu-Leu-V a l-T yr, where R is a reduced peptide bond, -CH 2 -N H -;
DD .
Szelke e t a i^  1982), has been used as an a ff in ity  ligand to  achieve the rapid 
iso lation of a highly purified  and stable renin preparation from  human renal 
cortex.
4.2 P u r i f ic a t io n  o f  re n in
A ll buffers contained 20mM-benzamidine,5mM-EDTA and 0.01%(v/v)
Tween 20.
Renal cortex (30g) was subjected to two cycles o f freezing and thawing 
and was then homogenised in 40ml of 50m M -Tris /H C l (pH 7 ,4 )/lm M - 
phenylmethanesuiphonyl fluoride /0 .5m M -N -e thylm a le im ide w ith  a Poiytron PT 20s 
homogeniser (5min, 25,000 rev/m in ). The homogenate was centrifuged fo r  
30min at 100,000g and 4°C. The supernatant solution was passed through a 
g lass-m icrofibre f i l te r  (Whatman GF/C) and im m ediate ly applied to a column 
(1.6cm X 5cm) o f H.77-Sepharose equilibrated w ith  ex trac tion  buffer. The 
column was washed w ith  100ml o f the same bu ffe r, w ith  100ml o f O .lM -T ris /H C l 
(pH 7 .4 )/lM -N aC l and fin a lly  w ith  100ml o f O.lM-sodium acetate (pH 6 .0 )/lM - 
NaCl. Renin was eluted w ith  a pH gradient generated by allowing 75ml of 
O .lM -ace tic  acid to  m ix w ith  75ml of O.lM-sodium acetate, pH 6.0. The flow  
ra te  was 0 .2m l/m in and 5ml fractions were collected.
The renin-conta in ing fractions were pooled and adjusted to pH 6.8 by
adding 2M -Tris. The enzyme was then concentrated by u ltra f ilt ra t io n  and stored
at -20°C  in 50%(v/v) g lycero l at a concentration of lOOpg/m l.
4.3 R e su lts  and d iscussion
In the above procedure crude ex trac t o f human renal cortex containing 
102 units of renin a c tiv ity  was applied to the column o f H.77-5epharose. A t 
pH 7.4 the renin a c t iv ity  was bound t ig h tly  by the im m obilised H.77 (Figure 
4.1). In contrast, non-specific acid proteinase a c t iv ity  did not bind and 
emerged from  the column w ith  the bulk prote in fra c tio n . A fte r  washing the 
column to remove weakly bound proteins, renin a c t iv ity  was eluted w ith  a pH
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F ig u re  4.1 A ff in ity  chrom atography of renin on H.77-Sepharose
Crude ex tra c t o f human kidney cortex was applied to a column o f H.77- 
Sepharose equ ilibrated w ith  extraction  bu ffe r. The column was washed w ith  
O .lM -T ris /H C l (pH 7 .4 )/lM -N aC l (arrow I) and then w ith  O.lM-sodium acetate 
(pH 6 .0 )/lM -N aC l (arrow II). Renin was eluted w ith  a pH gradient from  pH 6.0 
to pH 3.2 in O .lM -aceta te  bu ffe r (arrow III).
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gradient from  pH 6.0 to  3.2. This resulted in a 5500-fold increase in the 
specific  a c t iv ity  o f renin from  0.158 units/m g of prote in in the crude m ate ria l 
to  871 units/m g; 89jug o f purified  enzyme were obtained, representing a yie ld o f 
76% (Table 4.1).
The in s ta b ility  o f renin encountered in previous studies has been 
a ttr ib u te d  to  the presence o f contam inating proteinases and, in particu lar, to 
cathepsin D -like  a c t iv ity  (Inagami ^  aT, 1980). The purified  renin obtained in 
the present study exhibited no non-specific p ro teo ly tic  a c t iv ity  towards (^H) 
acetylhaemoglobin and was found to be stable over a period o f several months 
at pH 6.8 and -20°C .
The specific  a c t iv ity  o f human renin has been reported to  be 400 
units/m g by S later et (1978). These authors used the fluorescamine assay 
o f Bohlen et (1973) to  determ ine the protein content o f the pure enzyme. 
Values o f 830 units/m g (Yokosawa et 1978) and 950 units/m g (Yokosawa et 
a l., 1980) have been obtained fo r  spec ific  a c tiv ity  o f pure human renin using the 
method o f Low ry et a][, (1951) to  determ ine prote in concentration. The 
pu rified  renin obtained in the present study was found to  have a s im ila r spec ific  
a c t iv ity  (871 units/m g), the dye-binding method of B radford (1976) being used to  
measure pro te in  concentration.
The Mp value o f the purified  enzyme was determ ined both by gel
f ilt ra t io n  and by SDS-polyacrylamide gel electrophoresis. Standard proteins of 
known Mp were used to  ca lib ra te  a column of Sephadex GlOO (superfine grade)
and a standard curve o f versus log Mp was constructed (Figure 4.2). Gel
f i lt ra t io n  o f the pu rified  renin gave a single peak of renin a c tiv ity  corresponding 
to  an apparent Mp value of 40,000. This value compares well w ith  values
obtained in previous studies (Table 4.2). Exam ination o f the enzyme by
electrophoresis in the presence of 0.1% (w /v) SDS (Figure 4.3) showed tha t i t  
was not homogeneous, but consisted o f tWo d is tinc t polypeptides. The Mp
values o f these proteins, estim ated by comparison w ith  a standard curve of 
e lectrophore tic  m o b ility  versus log Mp (Figure 4.4) were 40,000 and 17,000 
respective ly. The larger prote in probably corresponds to  the renin o f Mp 
40,000 isolated previously (Table 4.2). The nature o f the 17,000 M^ protein is 
unclear at present, although i t  may represent a fragm ent o f renin formed by 
lim ite d  proteolysis. Galen et (1979) have reported the presence o f 
fragments o f renin w ith  apparent Mp values of 25,000 and 20,000 in a renin 
preparation (specific  a c tiv ity  860 units/m g) isolated from  a juxtaglom erular ce ll 
tumour o f renal cortex.
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Figure 4.2 Standard curve of Kgy versus log Mj. fo r  gel f iltra t io n  
of ac tive  renin
Gel f ilt ra t io n  o f active renin on Sephadex GlOO (superfine grade) was carried 
out as described in Section 2.7(a) using ^^C -m ethylated m arker proteins as 
in terna l standards. The standard proteins used were bovine serum albumin 
(66,200), ovalbumin (43,000) and carbonic anhydrase (29,000), 
taken from  the sources lis ted  in Table 2.2.
Mp values were
Table 4.2
The reported  Mp values of purified  ac tive  renin
Reference M r value Method o f measurement
This study 40,000 Gel f i lt ra t io n
This study 40,000 SDS/polyacrylam ide gel electrophoresis
S later ^  al .^, (1978) 40,000 SDS/polyacrylam ide gel electrophoresis
Yokosawa et (1980) 42,000 Gel f ilt ra t io n
Yokosawa et (1980) 41,000 Sedimentation equ ilibrium
Yokosawa ^  (1980) 40,000 SDS/polyacrylam ide gel electrophoresis
H igaki e t (1983) 40,000 Gel f ilt ra t io n
H igaki et (1983) 40,000 SDS/polyacrylam ide gel electrophoresis
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Figure 4.3. SDS/polyacrylam ide gel electrophoresis of purified renin
Discontinuous electrophoresis was carried out in a Im m -th ick  polyacrylam ide slab 
gel (stacking qel, 3% polyacrylam ide; resolvinq gel, ]0%  polyacrylamide). 
Protein bands were detected using the silver staining method of Wray et aL 
(1981). Track 2, 4 iig  of crude kidney cortex extract; track 3,]00ng of purified 
renin; tracks 1 and 4, standard Mp marker proteins: 50ng each of bovine serum 
albumin (66,200), pyruvate kinase (57,000), aldolase (40,000), carbonic anhydrase
(29,000), P-lactoglobulin P (]7,500) and lysozyme (]4,300). Subunit Mp values 
were taken from  the sources listed in Table 2.2.
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F ig u re  4 .4 . S tandard  c u rve  o f  e le c tro p h o re t ic  m o b il i ty  versus 
lo g  M r  fo r  S D S /p o lya c ry la m id e  ge l e le c tro p h o re s is  o f  
a c t iv e  re n in .
Discontinuous electrophoresis in the presence o f 0.1% (w /v) SDS was carried out 
in a Im m -th ic k  polyacrylam ide slab gel (stacking gel, 3% polyacrylam ide; 
resolving gel, 10% polyacrylam ide). The standard proteins used were bovine 
serum albumin (66,200), pyruvate kinase (57,000), aldolase (40,000), carbonic 
anhydrase (29,000), p -lactog lobu lin  B (17,500) and lysozyme (14,300). 
Subunit M r values were taken from  the sources lis ted in Table 2.2. The 
m obilities  o f the two proteins present in the purified  human renin preparation 
are indicated by arrows I (M^ 40,000 protein) and 11 (Mj. 17,000 protein) 
respective ly.
C H A P TE R  5
P U R IF IC A T IO N  OF IN A C T IV E  R E N IN  FRO M  H U M A N  R E N A L  C O R T E X .
5.1 In tro d u c tio n
A lthough inactive  renin has been purified  to homogeneity from  pig renal 
cortex (Inagami et ah, 1982c; Takii and Inagami, 1982), i t  has not yet been 
obtained in pure fo rm  from  human kidney. P a rtia l pu rifica tions  o f human renal 
inactive  renin have been achieved using dye ligand chrom atography, hydrophobic 
in te rac tion  chromatography and chromatography on pepstatin-Sepharose to  
achieve the com plete separation o f the active  and inactive  form s o f renin 
(Chang et 1981; A tlas et ^ . ,  1981; A tlas e t 1982b; Hsueh ^  
1983). A pa rtia l pu rifica tion  of human renal inactive  renin has also been 
obtained using a monoclonal immunoadsorbent, F15-Sepharose (Pau et ^ . ,  1981). 
In the present study, inactive  renin has been successfully isolated from  human 
renal co rtex using a com bination o f chromatography on H.77-Sepharose (to 
remove active  renin), ammonium sulphate frac tio na tion , hydrophobic in te rac tion  
chromatography on octyl-Sepharose and im m unoa ffin ity  chrom atography on F15- 
Sepharose.
5.2 P u r i f ic a t io n  o f  in a c t iv e  re n in
In order to  m inim ise the e ffe c ts  o f tissue proteinases on inactive  renin
during its  p u rifica tion , a ll manipulations o f the enzyme were carried out at 4°C
and the proteinase inh ib ito rs  benzamidine and EOT A were included in a ll buffers 
at concentrations of 20mM and 5mM respective ly.
(a) Chrom atography o f crude ex trac t of kidney co rtex  on H.77-5epharose 
The preparation o f crude ex tra c t o f renal co rtex and its  chromatography 
on H.77-Sepharose have already been described in Chapter 4. The pro te in - 
contain ing fractions which did not bind to the H.77-Sepharose were pooled and 
inactive  renin was fu rth e r pu rified  from  th is m ate ria l as described below.
(b) Ammonium sulphate frac tio na tion
The solution obtained in the above procedure (90ml) was made l.OM w ith  
respect to  ammonium sulphate by adding 12.8g o f crushed ammonium sulphate 
over a period o f 5 m in w ith  constant s tirr ing . A f te r  30 min, precip ita ted
prote in was removed by cen trifuga tion  fo r  10 min at 30,000g and 4°C . The 
supernatant solution (95ml) was adjusted to 2.6M w ith  respect to  ammonium 
sulphate by adding a fu rth e r 24.8g o f crushed ammonium sulphate over a period 
o f 15 m in. A f te r  the ammonium sulphate had dissolved, the solution was
s tirre d  fo r  60 m in and the resu ltan t p rec ip ita te  was co llected  by cen trifuga tion
fo r  15 m in a t 30,000g and 4°C . The precip ita ted  pro te in  was resuspended in
10ml o f 20mM-sodium phosphate (pH 7.0)/1.0M-ammonium sulphate and the 
suspension was dialysed overnight (16h) against 2 litre s  o f the same buffer w ith  
one change of dialysis bu ffe r a fte r  3h.
(c) Chromatography on octyl-Sepharose
The prote in solution obtained a fte r ammonium sulphate frac tiona tion  
(22ml) was applied to a column (1.6cm x 50cm) o f octyl-Sepharose equilibrated 
w ith  20mM-sodium phosphate (pH 7.0)/1.0M-ammonium sulphate. The column 
was washed w ith  400ml of the same bu ffe r and then w ith  400ml o f 20mM- 
sodium phosphate, pH 7.0. Inactive  renin was eluted using 20mM-sodium 
phosphate (pH 7.0)/50% (v /v) ethanediol/O.1% (v/v) Tween 20. The flow  ra te  
was 0 .5m l/m in  and 10ml fractions were co llected.
The frocPLorx^ cor^ xDUL/xcrq oaacrôe were pooled, dialysed against 2
litre s  o f 50m M -Tris /H C l fo r 5h w ith  changes o f dialysis b u ffe r every 30 m in and 
then concentrated to  a fin a l volume of 5ml by u ltra f ilt ra t io n .
(d) Chromatography on H.77-Sepharose/ri5-Sepharose
The prote in solution obtained above was passed through a column (1cm x 
2cm) o f H.77-Sepharose equ ilibrated w ith  50m M -Tris /H C l, pH 7.4 which was 
linked jn  tandem to  a column (1cm x 2cm) o f F15-Sepharose equ ilibrated w ith
the same bu ffe r. The columns were separated and the F15-Sepharose was 
washed w ith  5ml of 50m M -Tris/H C l, pH 7.4 and then w ith  5ml of lOOmM-
T ris /H C l, pH 7,4. Inactive renin was eluted w ith  2ml o f lOOmM-sodium
acetate, pH 4.5. The flow  ra te  throughout th is procedure was O .lm l/m in .
The eluate from  the F15-Sepharose was im m edia te ly concentrated by 
u ltra f ilt ra t io n  to a volume of about 100p i and then adjusted to pH 7.4 by
dialysis fo r  3h against 500ml o f lOOm M -Tris/HCl, pH 7.4. The purified  inactive  
renin was stored at -20°C  in 50% (v /v) g lycerol at a concentration o f lO pg /m l.
5.3 R e su lts  and d iscussion
The a f f in ity  chromatography o f crude ex tra c t o f renal cortex on H.77- 
SepharosB described in Chapter 4 was also used as the f ir s t  step in the 
p u rifica tio n  o f inactive  renin. As noted previously (Chapter 4), at pH 7.4, 
renin a c t iv ity  was bound tig h tly  by the im m obilised H.77. In contrast, inactive
renin did not bind and emerged from  the column w ith  the bulk protein fra c tio n
(Figure 5.1). This m ate ria l contained less than 0.1% o f the renin a c t iv ity
present in the in it ia l e x trac t of renal cortex (Table 5.1).
Ammonium sulphate frac tiona tion  o f the breakthrough fractions from  the 
H77-Sepharose resulted in a 4 -fo ld  increase in the specific  a c t iv ity  o f inactive  
renin and a fu rth e r 35-fo ld pu rifica tion  was achieved by hydrophobic in te rac tion  
chromatography on octyl-Sepharose (Figure 5.2). The inactive  renin eluted from  
the octyl-Sepharose (18.3 units) s t i l l  contained a small quantity  o f active  renin 
(4.7 m illiu n its ). This was removed by passing the inactive  renin through a 
small column o f H.77-Sepharose p rio r to the fin a l step o f pu rifica tion  which
involved a f f in ity  chromatography using a monoclonal immunoadsorbent, F15- 
Sepharose (Pau et ^ . ,  1981). Inactive  renin was bound by the im m obilished 
monoclonal antibody at pH 7.4 and was eluted by a change in pH to 4.5. This 
step resulted in a fu rth e r 105-fold pu rifica tion  o f the enzyme.
The pu rifica tio n  procedure described above produced an overa ll 14,750-
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Figure 5,1 Chrom atography of crude e x tra c t o f kidney cortex  
on H.77-Sepharose
Crude ex trac t o f human kidney cortex was applied to a column of H.77- 
Sepharose equ ilib ra ted w ith  ex trac tion  buffer* The column was washed w ith  
O .lM -T ris /H C l (pH 7 .4 )/lM -N a C l (arrow Ï) and then w ith  O.lM-sodium acetate 
(pH 6 .0 )/lM -M aC l (arrow  II). Renin was eluted w ith  a pH gradient from  pH 6.0 
to  pH 3.2 in O .lM -aceta te  bu ffe r (arrow III).
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Figure 5.2 Hydrophobic in te rac tio n  chrom atography o f inactive  
renin on octyî-Sepharoae
P a rtia lly  purified  inactive  renin in 20mM-sodium phosphate (pH 7.0)/l.O M - 
ammonium sulphate was applied to a column o f octyl-Sepharose equ ilibrated v /ith  
the same bu ffe r. The column washed w ith  20mM-sodium phosphate, pH 7.0
(arrow I). Inactive  renin was eluted v /ith  20mM-sodium phosphate (pH 7.0)/50% 
(v /v ) ethanediol/O.1% (v /v) Tween 20 (arrow II).
fo ld  increase in the specific  a c t iv ity  of inactive renin from  0.048 units/m g in 
the crude tissue ex tra c t to  708 units/m g; 12p g of purified  prote in were 
obtained, representing a y ie ld o f 27%. The purified  inactive  renin exhibited no 
a c t iv ity  towards angiotensinogen and was stable over a period o f several months 
at pH 7.4 and -20°C .
Throughout the p u rifica tio n  o f inactive renin, its  concentration was 
defined as the d iffe rence between the renin concentrations measured before and 
a fte r trypsin  ac tiva tion . The activa tion  o f inactive  renin was carried, out as 
described in Chapter 2 (Section 2.4(b)) by incubating samples at pH 7.4 w ith  600 
BAEE units o f trypsin  fo r  5h a t 4°C in the presence o f 20mM-benzamidine and 
1% (w /v) bovine serum albumin. This method was also used to  determ ine the 
spec ific  a c tiv ity  o f the purified  inactive  renin. In order to  check th a t the 
activa tion  procedure resulted in the maximum activa tion  o f inactive  renin 
w ithou t the concom itant destruction of the enzyme, the e ffe c t o f varying the 
trypsin  concentration and the tim e of incubation was investigated (Figure 5.3). 
Incubation o f the purified  inactive  renin w ith  600 BAEE units o f trypsin  at 4°C 
resulted in an increase in renin a c tiv ity  which reached a maximum value a fte r 
3h. The renin a c t iv ity  remained constant during a fu rth e r 4h o f incubation 
w ith  trypsin  ind ica ting tha t l i t t le  or no destruction o f renin occurred under 
these conditions. Incubation w ith  120 BAEE units o f trypsin  was less
e ffe c tiv e  in ac tiva ting  inactive  renin, m axim al ac tiva tion  being achieved only 
a fte r 5h. W ith 3,000 BAEE units o f trypsin, the increase in renin a c t iv ity  
occurred rap id ly , but was fo llow ed by a decrease in a c tiv ity .
Exam ination o f the purified  inactive  renin by electrophoresis in the 
presence o f 0.1% (w /v) SDS (Figure 5.4) showed tha t i t  consisted o f a single 
polypeptide chain. The Mj. value of the prote in estim ated by comparison w ith  
a standard curve o f e lectrophore tic  m ob ility  versus log Mp (Figure 5.5) was 
48,000. The size o f the purified  enzyme was also estim ated by gel f i l t ra t io n
on Sephadex GlOO (superfine grade). Comparison o f the e lu tion volume o f the 
inactive  renin w ith  a standard curve of versus log Mj. (Figure 5.6) yielded
an Mp value o f 51,000. This value is s im ila r to values previously obtained by 
gel f i l t ra t io n  o f p a rtia lly  purified preparations o f human renal inactive  renin 
(Table 5.2).
The purified  inactive  renin obtained in the present study is s im ila r in 
size to  the inactive  renin which has been isolated from  pig renal cortex 
(Inagami ^  ^ . ,  1982c; Takii and Inagami, 1982). The la tte r , like  human 
inactive  renin, consists of a single polypeptide chain o f M^ 50,000 and is 
com plete ly inactive  against angiotensinogen. Trypsin trea tm en t of pig inactive  
renin has been reported to result in the complete ac tiva tion  o f the enzyme and 
a reduction in its  size close to tha t o f the endogenous active  enzyme. The 
spec ific  a c t iv ity  o f purified  human inactive  renin, based on the renin a c tiv ity  
generated by trypsin  ac tiva tion , was 708 units/m g of inactive  renin. This is 
close to the value of 871 units/m g obtained fo r the purified  active  renin 
(Chapter 4). However, in contrast to  pig inactive  renin, trypsin  ac tiva tion  o f 
human inac tive  renin produced only a s ligh t reduction in the size o f the enzyme. 
The Mp of tryps in -ac tiva ted  inactive  renin determ ined by gel f i l t ra t io n  on 
Sephadex GlOO (superfine grade) was 47,000 (Figure 5.6) compared w ith  the 
value o f 40,000 fo r  endogenous active human renal renin (Chapter 4). This
d iffe rence in the behaviour of the pig and human inactive  renins presumably 
re fle c ts  a d iffe rence  in th e ir p rim ary structures.
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Figure 5.3 E f fe c t  o f  t ry p s in  c o n c e n tra tio n  on th e  a c t iv a t io n  
o f  in a c t iv e  re n in
Samples o f pu rified  inactive  renin (70pg/m l) in 50m M -Tris/H C i (pH 7.4)/20mM- 
benzam idine/5mM “E D T A /l%  (w /v) bovine serum albumin were activated using A ; 
120 BAEE units, B: 600 BAEE units, or C: 3,000 BAEE units o f trypsin. The 
samples (500ftl) were activa ted by adding the trypsin  in 50 itl o f Im M -H C I and 
incubating the m ixtures at 4°C fo r  varying periods o f up to  7h. In each case, 
the reacdon was stopped by adding 50n l o f SPTl solution (A: 0.4m g/m l, B: 
2m g/m l, C; lO m g/m l) in 50m M -Tris/H C l, pH 7.4 and the renin concentration was 
then determ ined as described in Section 2.4(a)
Mean + S.D. o f three determ inations.
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F ig u re  5.4 S D S /p o lyacry lam id e  gel e lectrophores is  o f p u rifie d
human renal in a c tiv e  ren in
Discontinuous electrophoresis was carried out on a Im m -th ick  polyacrylam ide 
slab pel (stacking pel, 3% polyacrylamide; resolving pel, 10% polyacrylamide). 
P rotein bands were detected using the silver staining method of Wray et 
(1981). Track 1, lOOng of purified renin; track 2, 50np of purified inactive 
renin; track 3, standard Mp marker proteins: 5Gnp each of bovine serum
albumuin (66,200), pyruvate kinase (57,000), aldolase (40,000), carbonic anhydrase
(29,000) and lysozyme (14,300). Subunit Mp values were taken from  the sources 
listed in Table 2.2.
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Figure 5.5 Standard curve of e lectrophoretic  m o b ility  versus log Mj. 
fo r  SD S/polyacrylam ide gel electrophoresis of 
inactive  renin
Discontinuous electrophoresis in the presence o f 0.1% (w /v) SDS was carried out 
in a Im m -th ic k  polyacrylam ide slab gel (stacking gel, 3% polyacrylam ide; 
resolving gel, 10% polyacrylam ide). The standard proteins used were bovine 
serum albumin (66,200), pyruvate kinase (57,000), aldolase (40,000), carbonic 
anhydrase (29,000) and lysozyme (14,300). Subunit Mp values were taken from  
the sources lis ted  in Table 2.2.
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Figure 5.6 Standard curve o f Kgv versus log fo r  gel f il t ra t io n  of 
in ac tive  renin and tryp s in -ac tiva ted  in ac tiv e  renin
Gel f i lt ra t io n  o f inactive  renin and o f tryps in -ac tiva ted  inactive renin was 
carried out as described in Section 2.7(a) using ^^C -m ethy la ted  m arker proteins 
as in te rna l standards. The standard proteins used were bovine serum albumin 
(66,200), ovalbumin (43,000) and carbonic anhydrase (29,000). Mp values were 
taken from  the sources lis ted  in Table 2.2. The Kgv values obtained fo r 
inactive  renin and tryps in  activa ted inactive  renin are ind icated by the arrows 
labelled IR and IR(T) respective ly.
76.
Table 5.2
The reported  Mp values of renal inactive  renin
Reference Mp value Method of measurement
This study 51,000 Gel f ilt ra t io n
This study 48,000 SDS/polyacrylam ide gel electrophoresis
A tlas ^  ai. (1981) 49,500 Gel f i lt ra t io n
Chang et aU (1981) 51,000 Gel f i lt ra t io n
Inagami e t (1983) 49,000-
50,000
SDS/polyacrylam ide gel electrophoresis 
w ith  im m unospecific staining.
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C H A P TE R  6
TH E REVERSIBLE A C T IV A T IO N -IN A C T IV A T IO N  OF IN A C T IV E  R E N IN
6.1 In troduction
As discussed in Chapter 1, plasma inactive  renin can be activa ted  by 
dialysis o f plasma to a pH of between 3.0 and 3.3 fo llow ed by dialysis to  
neutra l pH. The ac tiva tion  o f plasma inactive  renin which is produced by th is 
m anipulation is irrevers ib le  and has been shown to depend on the action o f 
endogenous serine proteinases during the dialysis o f ac id ified  plasma to  neutra l 
pH (A tlas e t 1978; Leckie , 1978). Recently, Leckie  and McGhee (1980) 
and Hsueh et ^ . ,  (1981) have shown tha t the ac id ifica tio n  o f plasma per se 
results in the com plete ac tiva tion  o f inactive  renin and th a t i f  plasma serine 
proteinase a c t iv ity  is inh ib ited, th is  ac tiva tion  can be reversed by dialysis o f the 
ac id ified  plasma to  neutra l pH. The reversible ac tiva tion  o f inactive  renin has 
also been demonstrated using p a rtia lly  purified  inactive  renin from  human kidney 
(Chang et 1982; A tlas et ah, 1982b; Hsueh e t ^ . ,  1983) or am nio tic  flu id  
(Franks et 1982), but has not yet been demonstrated using pure inactive  
renin.
6.2 R evers ib le  a c id -ac tiv a tlo n  o f pure human renal in ac tiv e  renin
A ll buffers contained 20mM-benzamidine 5mM-EDTA and 1% (w /v) bovine 
serum albumin.
Pure human inactive  renin was d ilu ted to  a f in a l concentration o f 7ng/m l 
in lO O m M -Tris/H C l, pH 7.4 containing ^^C -m ethyla ted bovine serum albumin 
(100,000 cpm /m l). 400p i samples o f th is solution were ac id ified  by dialysis
against 1 l i t r e  o f lOOmM -glycine/HCl, pH 3.3 fo r 24h at 4°C and were 
subsequently adjusted to  neutra l pH by dialysis against 1 l i t r e  o f lOOmM- 
T ris /H C l, pH 7.4 fo r 24h at 4°C . A fte r  each period o f dialysis, the samples 
were assayed fo r  renin a c t iv ity  at neutra l pH as described in Section 2.4(a)i In
each case, the concentration o f ^^C -m ethylated bovine serum albumin was 
determ ined by liqu id  sc in tilla tio n  counting of 50 p i of the dialysed solution in 
8ml of Packard s c in tilla to r 299, and th is value was used to  co rrec t the renin 
a c t iv ity  measurement fo r any changes in sample volume which had occurred 
during dialysis.
6.3 Results and discussion
Figure 6.1 shows tha t human renal inactive  renin was activa ted  by dialysis 
to  pH 3.3 and th a t th is activa tion  was reversed by dialysis back to  neutra l pH. 
I f  th is m a te ria l was subsequently ac id ified , then the inactive  renin was re ­
activa ted  ind ica ting tha t the loss o f renin a c tiv ity  during the dialysis of 
ac id ified  inactive  renin to neutra l pH was not due to the irreversib le  
dénaturation o f the enzyme.
The ra te  o f angiotensin I generation by the acid- activa ted  inactive  renin 
was non-linear w ith  tim e (Figure 6.2) due to the re -inac tiva tion  of the enzyme 
during its  incubation w ith  ox renin substrate at neutra l pH. When short 
incubation tim es were used (10 min or less) to assay renin a c tiv ity , the m axim al 
a c t iv ity  produced by the ac id ifica tio n  of inactive  renin (3.93 + 0.21 ng A l/h /n g  
inactive  renin) was comparable to  tha t produced by tryps in -ac tiva tion  (4.1 + 0.19 
ng A l/h /n g  inactive  renin).
Leckie  and McGhee (1980) have postulated th a t the reversible ac tiva tion  
o f inactive  renin is due to  the dissociation and re-association o f a ren in -inh ib ito r 
complex. In contrast, Hseuh et aL (1981) have suggested tha t ac id ifica tion  
induces a pa rtia l unfolding o f a single chain inactive  renin to  expose the active  
s ite  o f the enzyme. In support of the la tte r  hypothesis. A tlas e t ^  (1982a) 
have reported tha t the re -inac tiva tion  o f ac id ified  inactive  renin is a f irs t  order 
process, a find ing which is consistent w ith  a unimolecular reaction ra ther than a 
b im olecular reaction. U n fo rtuna te ly , however, the inactive  renin used ta the 
above study was only p a rtia lly  pu rified  and thus the pseudo-first order reaction
o f ren in w ith  a large excess of an in h ib ito r prote in could not be excluded as a 
possible explanation o f the experim enta l data. In the present study, the single 
chain inactive  renin purified  from  human renal co rtex has been shown to  be 
revers ib ly  activa ted  by ac id ifica tion , ind ica ting tha t the phenomenon is indeed 
due to  a pH-induced conform ational change in a single polypeptide chain ra ther 
than to  the dissociation o f a ren in -inh ib ito r complex.
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Figure 6.1 R eversib le ac id -ac tivà tio n  of in active  renin
Samples of inactive  renin diluted to  a concentration o f 7ng/mî in lOOmM- 
T rîs /H C l (pH 7,4)/20m M -benzam idine/5m M -EDTA/l%  (w /v) bovine sérum albumin 
were adjusted to pH 3.3 by dialysis fo r  24h at 4°C against lOOmM-glycine/HCI 
(pH 3.3)/20m M -benzam idine/]%  (w /v) bovine serum albumin. The samples were 
readjusted to pH 7.4 by dialysis fo r 24h at 4°C against lOOm M -Tris/HCl (pH 
7.4)/20m M -benzam id ine/l%  (w /v) bovine serum albumin. A fte r  each period o f 
dialysis the samples were assayed fo r renin a c t iv ity  as described in Section 
2.4(a), Each point (O) represents the mean + SD of five  experiments. Samples 
o f inactive  renin 7ng/m l) were also try p s in -a c tiva te d  as described In Section 
2.4(b); # ,  mean + SD of five  experiments.
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F igure 6.2 T im e course of angiotensin I generation by ac id -ac tiva ted  
inactive  renin
Samples o f ac id -activa ted  inactive  renin were d ilu ted to  a concentration of 
70pg/m l in 50m M -Tris/H C i (pH 7.4)/20m M -benzam idine/l%  (w /v) bovine serum 
albumin and im m edia te ly assayed fo r  renin a c tiv ity  as described in Section 
2.4(a). Incubations were carried out fo r periods o f up to  f ive  hours. Mean + 
SD of five  determ inations.
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C H A P TER  7
S T R U C TU R A L CO M PAR ISO N OF THE A C TIV E  A N D  IN A C T IV E
FORMS OF R E N IN
7.1 In troduction
As discussed in Chapter 1, i t  has been suggested tha t inactive  renin is a
b iosynthetic precursor o f renin analogous to  the w e ll known zymogens pepsinogen 
and trypsinogen (Sealey e t 1982a).
The inactive  renin purified  in the present study consists o f a single 
polypeptide chain and is s ligh tly  la rger than its  ac tive  counterpart. The
purified  prote in is com plete ly inactive  against ox angiotensinogen, but can be 
activa ted  by lim ite d  proteolysis. Previous studies using p a rtia lly  purified  
inactive  renin have shown tha t trypsin  activa ted inactive  renin and endogenous 
active  renin are s im ila r, both im m unologically and w ith  respect to  the ir k in e tic  
properties (A tlas et ah, 1982b; Hsueh ^  1983). These data strongly
suggest tha t inactive  renin is indeed a renin zymogen.
In order to  obtain d irec t evidence fo r a s truc tu ra l re la tionship between 
active  renin and inactive  renin, the two form s of the enzyme have been
compared by peptide ’mapping',
7.2 Peptide 'mapping* of the ac tive  and in active  form s of renin
(a) Radio labellinq o f proteins
Prote in  samples were radio labelled using the method of Bolton and
H unter (1973). In this method the protein is trea ted  w ith  a ^^^I-labe lled
acylating reagent, N -succin im idyl-3-(4-hydroxy,5-(^^^I)iodophenyl)propionate 
(Bolton-H unter reagent), which reacts w ith  free amino groups on the prote in 
m olecule.
Sample preparation 50p i samples (2pg) o f pu rified  active renin, 
pu rified  inactive  renin, and o f a m ix ture  o f standard proteins (0.4pg each o f
pyruvate kinase, ovalbumin, aldolase, carbonic anhydrase and g-lactog lobu lin  B) 
were dialysed exhaustively at 4°C against lO O m M -triethanolam ine/HCI, pH 8.5 
and were adjusted to  a fin a l volume o f BOpl using the same bu ffe r. 20p i of 
10% (w /v) SDS was added to each sample. The prote in solutions were heated 
to  100°C in a boiling w ater bath fo r  3 min and were then cooled to  4°C.
Radio labellinq o f samples Ip g  of each pro te in  sample (50p i) was
reacted w ith  300 pmoles o f labelled Bolton-Hunter reagent. In each case, the
reagent (600pC i) dissolved in 50p i o f benzene/0.2% (v /v) d im ethylform am ide,
was p ipetted in to  a sm all glass v ia l (5mm x 15mm) and then dried by 
evaporation o f the solvent at room tem perature under a flo w  o f nitrogen. The 
prote in sample was added to  the dried reagent and the reaction m ix tu re  was 
shaken fo r 30min at 4°C. The reaction m ixture  was then transferred to  a 
second glass v ia l (5mm 15mm) containing 10pmoles o f unlabelled Bolton-Hunter 
reagent (N -succin im idyl-3-(4-hydroxyphenyl)propionate and shaken fo r  a fu rth e r 
30min a t 4°C . In order to  obviate the subsequent labelling o f ca rrie r proteins, 
unchanged B o lton-H unter reagent was reacted w ith  50p i o f lOOm M -Tris/HCl, pH 
8.5 fo r  lOm in at 4°C . F ina lly , 100 p i o f lOO m M -Tris/HC i, pH 8.5 containing 
200 p g o f bovine serum albumin as ca rrie r prote in was added to  the labelled 
prote in.
P u rifica tio n  o f labelled proteins The labelled proteins were 
separated from  the other labelled products o f the acyla tion reaction (acylated 
Tris and 3-(4-hydroxy,5-(^^^I) iodophenyl)propionic acid) by p rec ip ita tion  w ith  1ml 
o f ice-co ld  10% (w /v) trich lo ro a ce tic  acid. In each case, the p rec ip ita ted  
prote in was allowed to  stand fo r  15min on ice and was then co llected by 
cen trifuga tion  at lOOOg and 4°C fo r  5min. Each p rec ip ita te  was washed once 
w ith  a fu rth e r 1ml o f ice-co ld 10% (w /v) tr ich lo ra ce tic  acid and tw ice  w ith  1ml 
o f ice-co ld  acetone w ith  the same cen trifuga tion  each tim e.
The labelled proteins were fu rth e r purified  by polyacrylam ide gel
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electrophoresis in the presence o f 0.1% (w /v) SDS. Each prote in p rec ip ita te  
was dissolved in 50p i o f sample bu ffe r (72.5mM T ris /H C l (pH 6.8)/3% (w /v) 
SDS/10% (v /v) g lycero l/5%  (v/v) 2-mercaptoethanol/0.002%  (w /v) bromophenol 
blue and electrophoresis was carried out as described in section 2.6(a) using rod
gels (10% resolving gels). A fte r  electrophoresis was com plete, the gels were
frozen using powdered dry ice. The gels were sliced in to  1mm segments using 
a manual gel s lice r (Bio-Rad model 190) and the segments were then counted 
fo r
Labelled proteins were eluted from  the polyacrylam ide gel by crushing 
the appropriate gel segments w ith  a glass rod and incubating the gel fragments 
fo r  24h at 4°C w ith  300p i o f lOOmM-ammonlum bicarbonate/0.01%  (w /v) bovine 
serum albumin (e lution buffer). In each case, the gel s lu rry was then poured 
in to  a 1ml disposable p ipette  t ip  containing glass wool and the liqu id  was 
separated from  the gel fragments by centrifugation  fo r 2min at 500rpm in a 
benchtop cen trifuge . The gel s lu rry was rinsed w ith  a fu rth e r 200 p i o f e lu tion 
bu ffe r and centrifuged again fo r 2min at 500rpm. The combined eluates were 
then frozen and the labelled proteins were stored at -20°C .
(b) C leveland mapping
One dimensional peptide mapping o f labelled proteins isolated from
polyacrylam ide gels was carried out by the method o f C leveland e t (1977).
A 12.5% SDS/polyacrylam ide slab gel was prepared as described in section 2.6(a). 
Gel 'chips' containing labelled proteins were cu t from  polyacrylam ide gels w ith  a 
scalpel and soaked fo r  30 min w ith  occasional shaking in 72.5m M -Trls/HC l (pH 
6.8)/0.1% (w /v) SDS. Sample wells were f ille d  w ith  th is  bu ffe r and each gel
'chip' was pushed to  the bottom  o f a w e ll w ith  a spatula. Spaces around the 
'chips' were f ille d  by overlayering w ith  10p i o f the same bu ffe r containing 20% 
(v/v) g lycero l. F ina lly , 10p i o f the same bu ffe r containing 10% (v/v) g lycero l 
and 500ng of V8 proteinase was layered on top o f each gel chip and 50p i
samples o f a prote in m ix tu re  containing 5pg each o f ovalbumin, aldolase, 
carbonic anhydrase, soybean trypsin  inh ib ito r and lysozyme in electrophoresis 
sample b u ffe r were layered in to  adjacent sample wells. E lectrophoresis was
carried out at constant current (12mA) u n til the track ing  dye had reached the
end o f the stacking gel when the curren t was sw itched o f f  fo r  30min to  allow 
digestion o f the labelled proteins by the V8 proteinase to  take place. The 
current was then restored and electrophoresis was continued at constant curren t 
(25mA) u n til the track ing  dye had trave lled  the length o f the resolving gel. 
The gel was fixed  and stained fo r prote in using Coomassie B r illia n t Blue. 
Radio labelled prote in fragm ents were detected by in d ire c t autoradiography as 
described in section 2.6(b).
(c) Peptide mapping by analysis V8 proteinase digests using high 
performance liqu id chromatography (HPLC)
HPLC solvents were argon degassed fo r  each experim ent. 
T riflu o ro a ce tic  acid (0.1% (w /v)) was passed through a 0.2 pm M illip o re  f i l te r  
before use.
Samples (2G0,000cpm) o f labelled active  renin and labelled inactive  renin 
in 200p i of lOOmM-ammonium bicarbonate/0.01%  (w /v) bovine serum albumin 
were exhaustively digested by incubation w ith  5 p i o f V8 proteinase solution 
( Im g /m l in lOOmM-ammonium bicarbonate) fo r 24h at 37°C and then w ith  a 
fu rth e r 5 p i o f the proteinase solution fo r  6h at 37°C.
Analysis o f the prote in digests was carried out using a Gilson model 303
com puter contro lled  gradient pumping HPLC system (Scotlab L td ., Righead 
Industria l Estate, B e llsh ill, Scotland) f i t te d  w ith  a pBondapak C^g reverse phase 
column (Waters Associates (Instruments) L td ., H a rtfo rd , U .K .). Each pro te in  
digest was lyophilised and resuspended in 25 p i of 0.1% (w /v ) tr if lu o ro a c e tic  acid. 
20p i o f th is solution was applied to  the column using a valve loop in jec to r and 
the chromatogram was developed over 80min using a 0-40% gradient o f
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isopropanol in 0.1% (w /v) tr if lu o ro a c e tic  acid a t a flow  rate o f Im l/m in . 
300p i frac tions were co llected and counted fo r  ^^^1.
7.3 R e su lts  and d iscussion
Peptide mapping techniques involving the de tection o f resolved peptides 
using ninhydrln or fluorescam ine generally require nanomolar quantities o f 
prote in as s ta rtin g  m a te ria l. In order to compare the active  and inactive  
form s of renin by peptide mapping using the small quantities o f m ate ria l 
pu rified  in the present study, the proteins were f ir s t  radio labelled by reaction 
w ith  the ^^^I-labe lled  acylating reagent, N -succin im idyl-3-(4-hydroxy,5- 
(^^^DiodophenyDpropionate (Bolton-H unter reagent). This reagent labels both 
lysine and te rm ina l amino groups.
Ip g  o f each prote in preparation was reacted w ith  300pmoies o f labelled 
acyla ting reagent (600pC i), and then w ith  an excess o f unlabelled reagent in 
order to ensure com plete m od ifica tion  o f the proteins. The labelled proteins 
were separated from  other labelled products of the reaction  by p rec ip ita tion  
w ith  tr ich lo ro a ce tic  acid fo llow ed by polyacrylam ide gel electrophoresis in the 
presence o f 0.1% (w /v) SDS, carried out in rod gels. Exam ination o f these gels 
by s lic ing each gel in to  1mm segments and counting the segments fo r 
(Figure 7.1) showed tha t both the active  and inactive  form s of renin had been 
successfully labelled. As expected the labelled ac tive  renin preparation 
contained tw o labelled proteins (I and II). The Mp values o f these proteins, 
estim ated by comparison w ith  a standard curve o f electrophoresis m o b ility  versus 
log Mp (Figure 7.2), were 41,000 and 17,000 respective ly. The labelled inactive  
renin preparation contained a single labelled polypeptide o f Mp 49,000.
The labelled active  renin (Mp 42,000, 1.35xl0^cpm ) and labelled inactive  
renin (6 .6xl0^cpm ) were recovered from  the gels by crushing the appropriate gel 
segments w ith  a glass rod and e lu ting the proteins in to  lOOmM-ammonium 
bicarbonate/0.01%  (w /v) bovine serum albumin as described in the preceding
A; Active Renin
Dye
fron t4 0 0 -
2 0 0 -
Dye
fron tB: Inactive Renin4 0 0 -
2 0 0 -E
5
X
o
C: Standard Proteins
Dye
fro n t6 0 0 -
4 0 0 -
200-
10 20 30 40 6050
Slice Number
Figure 7.1 SD S/polyacrylam ide gel electrophoresis of ^25 i.iab e lled
proteins
Discontinuous electrophoresis was carried out in rod gels (stacking gel, 3% 
polyacrylam ide; resolving gel, 10% polyacrylam ide). A fte r  electrophoresis was 
com plete, the qels were sliced in to 1mm segments and the segments were then 
counted fo r 125;^ A, labelled active renin preparation; B, labelled inactive  
renin preparation; C, labelled standard Mj. proteins: PK, pyruvate kinase
(57.000); OV, ovalbumin (43,000); A, aldolase (40,000); CA, carbonic anhydrase
(29.000); P-LO, P -lactoglobulin B (17,500). Subunit Mp values were taken from  
the sources lis ted  in Table 2.2,
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F igure 7.2 Standard curve of e lectrophoretic  m o b ility  versus log M
fo r  SD S/polyacrylam ide gel 
labelled  proteins
electrophoresis of
Discontinuous electrophoresis in the presence o f 0.1% (w /v) SDS was carried out 
in rod qels (stacking gel, 3% polyacrylam ide; resolving gel, 10% polyacrylam ide). 
The standard proteins used were pyruvate kinase (57,000), ovalbumin (43,000), 
aldolase (40,000), carbonic anhydrase (29,000) and P-lactog lobulin  U7,500). 
Subunit M r values were taken from  the sources lis ted  in  Table 2.2. The 
m obilities  of the tw o proteins present in the labelled preparation o f active renin 
are ind icated by arrows I and II respective ly. The m o b ility  o f labelled inactive  
renin is indicated by arrow III.
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section (7.2(a)). The recoveries o f labelled proteins in th is  procedure were
8.5xl0^cpm  (63%) fo r  the active  fo rm  of renin and 4.7xl0^cpm  (71%) fo r 
inactive  renin.
In order to  check th a t the labelled proteins had not been fragm ented in 
the above procedure, samples o f each eluate were examined by electrophoresis 
in the presence o f 0.1% (w /v) SDS (Figure 7.3). In each case a single
polypeptide was observed.
The Bo lton-H unter reagent has been used in numerous studies to  label 
proteins to  spec ific  ac tiv itie s  in the range 20-200p C i/p g  prote in (Langone, 
1981). U n fo rtuna te ly , the e ffic ien cy  o f the acylation reaction  is dependent on
the concentration o f prote in in the reaction  m ixture . I t  is m arkedly reduced
at pro te in  concentrations below 500pg/m l (Bolton and H unter 1973). In the 
present study in which the prote in concentration in the reaction m ix tu re  was
only 16pg /m l, the yields o f labelled proteins were correspondingly low, being 
less tha t 2 p C i/p g  prote in fo r the labelled active  and inactive  renins.
In spite o f th is re la tiv e ly  poor labelling e ffic ie n cy , the use o f the 
B o lton-H unter reagent to in troduce ^^^I in to  proteins has at least two m ajor 
advantages over d irec t methods o f prote in iodination. F irs t ly , the acylation
reaction  is extrem ely m ild  and avoids the risk o f possible protein damage 
associated w ith  d irec t iodination methods using chem ical oxidants such as a 
chloram ine-T (Hunter and Greenwood, 1972). The risk o f oxidative damage to  
proteins can be reduced by using lactoperoxidase to  catalyse prote in iodination 
(Thorell and Johansson, 1971). However, th is enzym ic method is not
appropriate in cases such as the present study where pro te in  iodination is 
ca rrried  out under denaturing conditions in order to  ensure extensive labelling o f 
in te rna l residues. A second advantage o f the use o f the Bo lton-H unter reagent 
is th a t i t  avoids d irec t exposure o f proteins to  labelled iodine. There is some 
evidence (Hunter, 1971) tha t proteins may be damaged during d irec t
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F ig u re  7 .3 . S D S /p o lyacry lam id e  gel e lectrophores is  o f ^ ^ ^ I-lab e lled
a c tiv e  ren in  and l^ ^ I- la b e lle d  in a c tiv e  renin
Discontinuous electrophoresis was carried out in a Im m -th ick  polyacrylam ide slab 
qel (stacking qel, 3% polyacrylam ide; resolvinq qel, 12.5% polyacrylam ide). The 
gel was fixed and stained fo r protein using Coomassie B rillia n t Blue. 
Radiolabelled proteins were detected by ind irect autoradiography fo r 24h as 
described in Section 2.6(b). Track 1, 5,000cpm of ^^^I-labelled inactive renin; 
track 2, 5,000cpm of ^^^I-labelled active renin; track 3, Coomassie B rillia n t 
Blue stained standard Mp marker proteins; 5 iiq  each of ovalbumin (43,000), 
aldolase (40,000), carbonic anhydrase (29,000), soybean trypsin inh ib ito r (20,100) 
and lysozyme (14,300). Subunit Mp values were taken from  the sources listed in 
Table 2.2.
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rad io iod ination by noxious im purities present in solutions o f of high spec ific
ra d io a c tiv ity .
An in it ia l comparison o f the active and inactive  form s of renin was 
carried out by lim ite d  proteolysis and analysis o f the cleavage products by gel 
electrophoresis in the presence o f 0.1% (w /v) SDS (Cleveland mapping).
Cleavage o f the labelled proteins was carried out using V8 proteinase from  S. 
aureus which cleaves proteins on the C -te rm ina l side of g lutam ate and aspartate 
residues (Drapeau, 1976). A lthough the cleavage patterns produced by the two 
form s o f renin (Figure 7.4) were not identica l, four bands (VIII, IX , X and X I) 
were common to both digests, ind ica ting at least a pa rtia l s truc tu ra l homology 
exists between active  renin and inactive  renin.
A more extensive comparison of the two form s of renin was carried out 
by exhaustive digestion o f the labelled proteins w ith  V8 proteinase fo llowed by 
analysis o f the digests by reverse phase high performance liqu id  chromatography
(HPLC). Nine labelled peptides were resolved by HPLC 'mapping' o f active
renin (Figure 7.5), Each of these peptides was also present in the digest of 
inactive  renin ind ica ting tha t there are extensive regions o f common sequence in 
the ac tive  and inactive  forms of renin. The digest o f inactive  renin also 
contained three labelled peptides (III,VI and X I) which were not present in the 
active  renin digest. These data are c learly  consistent w ith  the hypothesis th a t 
inactive  renin is a renin zymogen.
The activa tion  o f a renin zymogen should, by analogy w ith  pepsinogen 
ac tiva tion , involve the removal o f a short polypeptide from  the N -te rm ina l end 
o f the zymogen, thus generating a new N-term inus. A lthough the Bo lton- 
H unter reagent labels te rm ina l amino groups in proteins, the peptide maps 
obtained in the present study (Figure 7.5) do not show the expected ex tra
peptide corresponding to the N -te rm ina l sequence of active  renin. A lthough
possible, i t  is un like ly tha t th is is due to the fa ilu re  of the HPLC technique to
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F ig u re  7.4 Cleveland maps of the active and inactive  forms of renin
One dimensional peptide mapping of ^^^I-labeiled active renin and ^^^I-labelled 
inactive renin was carried out using the method of Cleveland et (1977).
Discontinuous electrophoresis in the presence of 0.1% (w /v) SDS was carried out 
in a Im m -th ick  polyacrylam ide slab qel (stacking qel, 3% polyacrylamide: 
resolving qel, 12.5% polyacrylam ide). Del 'chips' containing the labelled
proteins were applied to the qel and overlayered w ith  VB proteinase (500ng) as 
described in Section 7.2(b). Digestion of the proteins was carried out w ith in
the polyacrylam ide gel by sw itching o ff  the current fo r 30 min when the
tracking dye had reached the end of the stacking qel. The gel was fixed and 
stained fo r protein using Coomassie B rillia n t Blue. Radiolabelled proteins were 
detected by ind irect autoradiography fo r 7 days as described in Section 2.6(b). 
Track 1, 5,000cpm of ^^^1-labelled active renin; track 2, 5,000cpm of 1 ^^1- 
labelled inactive renin; track 3, Coomassie B rillia n t Blue stained standard Mp 
marker proteins; 5ug each o f ovalbumin (43,000), aldolase (40,000), carbonic 
anhydrase (29,000), soybean trypsin inh ib itor (20,100) and lysozyme (14,300).
Subunit Mp values were taken from  the sources listed in Table 2.2.
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Figure 7.5 H P LC  analysis o f V8 proteinase digests o f th e  ac tive  and
inactive  form s o f renin
V8 proteinase digests o f i25 i_ iabelled active renin and 125i4abgHed inactive  
renin (c irca  170,000cpm o f each preparation) were analysed by high performance 
liqu id  chromatography. Each digest, dissolved in 25 u l o f 0.1% (w /v)
tr if lu o ro a c e tic  acid, was applied to  a uBondapak Cj_g reverse phase column and 
the chromatogram was developed over 80 min using a 0-40% gradient o f 
isopropanol in 0.1% (w /v) tr iflu o ro a ce tic  acid at a flow  rate o f Im l/m in . 
300u l fractions were co llected and counted fo r
separate this peptide from  the other labelled peptides in the digest o f active 
renin.
One possible explanation fo r  th is find ing is tha t the N -te rm ina l sequences 
o f the active  and inactive  form s of renin are iden tica l. This, however, is
un like ly since there is no sequence homology between the N -te rm ina l regions of 
the active  form s and zymogen form s of other aspartic proteinases, such as 
pepsin or chymosin (Foltmann and Pedersen, 1977), or between the N -te rm ina l 
regions o f the product and precursor form s of mouse subm axillary gland renin 
(Panthier et a l., 1982a). A more a ttra c tiv e  explanation fo r the absence o f a 
unique N -te rm in a l peptide in the 'map* of active renin is th a t i t  re fle c ts  N -
te rm ina l heterogeneity in the active  renin preparation used in the present study, 
the quantities o f each N -te rm ina l peptide present in the digest of active  renin 
being in su ffic ie n t to appear as a d is tinc t peak a fte r  analysis by HPLC. Such 
heterogeneity is not unexpected since the enzyme has been purified from  post 
m ortem  m ate ria l and w ill,  therefo re , have been exposed, at least b r ie fly , to  a 
va rie ty  o f tissue proteinases during the period between death and the removal o f 
the kidney at autopsy. A lte rn a tive ly , N -te rm ina l heterogeneity in active  renin 
could arise i f  the jn  vivo ac tiva tion  of inactive  renin involved an ac tiva ting
proteinase o f broad substrate sp e c ific ity , or i f  the ac tiva tion  mechanism involved 
several sequential cleavage steps. The appearance o f ac tive  renin (Mj. 40,000)
as a broad band a fte r electrophoresis in the presence o f 0.1% (w /v) SDS,
compared to the w e ll defined band produced by inactive  renin (Figure 7.6) is 
consistent w ith  the la tte r  hypothesis. However, since renin is a g lycoprotein, 
th is  appearance may be due to  heterogeneity in the carbohydrate components of 
renin ra the r than to heterogeneity in the polypeptide chain. Further
experiments w ill be required to c la r ify  the above points.
The data presented in th is chapter ind ica te tha t there are extensive
regions o f common sequence in the active and inactive  form s of renin and
there fo re  suggest th a t inactive  renin is indeed a renin zymogen. This 
in fo rm ation  was obtained from  experiments using extrem ely small amounts o f 
m ate ria l; the enzyme digests were performed on less than lOpmoles o f each 
protein. F ina l proof o f a precursor-product re la tionship between inactive renin 
and active  renin w ill require the to ta l sequence analysis o f each protein. This 
w e ll require much la rger amounts o f the proteins than are available a t the 
present tim e.
96
1 2 3 10”^x Mr
- 66 .2
— 57
— 40 
— 29
- 1 4 . 3
F ig u re  7.6  S D S /p o lyacry lam id e  gel e lectrophoresis  o f p u rifie d
a c tiv e  ren in  and p u rifie d  in a c tiv e  ren in
Discontinuous electrophoresis was carried out on a Im m -th ick  polyacrylamide 
slab qel (stacking qel, 3% polyacrylamide; resolving qel, 10% polyacrylamide). 
Protein bands were detected using the silver staining method of Wray et 
(1981). Track 1, lOOng of purified renin; track 2, 50nq of purified inactive 
renin; track 3, standard Mp marker proteins: 5Gng each o f bovine serum
albumuin (66,200), pyruvate kinase (57,000), aldolase (40,000), carbonic anhydrase
(29,000) and lysozyme (] 4,300). Subunit Mp values were taken from  the sources 
listed in Table 2.2.
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C H A P TE R  8 
G E N E R A L DISCUSSION
8,1 In tro d u c t io n
In recent years i t  has become apparent th a t many proteins are
synthesized as inactive  precursors, or zymogens, which are subsequently
converted to  physio logica lly active  form s by se lective  enzym atic cleavage. 
Zymogen ac tiva tion  serves as a ra te  contro lling  step in a va rie ty  o f biological 
processes, such as blood coagulation, fib rino lys is , complement reaction,
d iffe re n tia tio n  and supramolecular assembly (Neurath and Walsh, 1976)- The 
presence o f an inactive  fo rm  of renin, both in renal co rtex  and in plasma, which 
can be activa ted  by lim ite d  proteolysis, has the re fo re  prompted some 
investigators to  suggest tha t th is fo rm  of renin may be a c ircu la ting renin
zymogen, and th a t its  ac tiva tion  e ither w ith in  the c ircu la tion  or at a s ite d istal 
to  its  s ite  o f synthesis may fo rm  the basis o f a con tro l mechanism fo r
m odulating the a c t iv ity  of the renin-angiotensin system (Schalekamp and D erkx, 
1981; Sealey et 1982a).
W hile the existence of a b iosynthetic precursor o f renin (prorenin) has 
been demonstrated Jri v itro , both by the ce ll free  translation o f mouse 
subm axillary gland mRNA (Lund et ^ . ,  1982), and by pulse-chase experiments
carried out using isolated canine glom eruli (Carlson ^  1981) and mouse
subm axillary gland tissue (Dzau et aL, 1982), previous studies have fa iled  to
provide conclusive evidence tha t the inactive  fo rm  of renin present in renal 
cortex and in plasma is a precursor of active renin.
The data obtained in the present study show th a t as expected fo r a
renin zymogen, inactive  renin purified  from  human renal cortex consists o f a 
single polypeptide chain (Mp 48,000) which is s ligh tly  la rger than its  active  
counterpart (Mp 40,000). Furtherm ore, peptide 'mapping' o f active renin and
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inactive  renin has shown tha t extensive regions of common sequence exist in the 
tw o form s of the enzyme. Although fin a l proof of a precursor-product 
re la tionship between inactive  renin and active  renin w ill require the to ta l 
sequence analysis o f each prote in, the above results provide the most convincing 
evidence to  date th a t renal inactive  renin is a renin zymogen. C learly , 
however, a number o f im portant questions remain unanswered.
1. In man, between 70% and 90% of the to ta l c ircu la ting  renin is present
as an inactive  form  of the enzyme. Is th is m a te ria l, like  renal inactive  
renin, a renin zymogen and i f  so, is i t  released in to  the c ircu la tion  from
the kidney or from  extrarenal sites of renin synthesis?
2. A ll zymogen activa tion  reactions require the enzyme-catalysed cleavage 
of a unique peptide bond by ’lim ite d  proteolysis’. What enzyme or 
enzymes are responsible fo r the activa tion  o f inactive  renin and where 
does th is process occur jn  vivo?
3. Does the ac tiva tion  o f inactive  renin form  the basis o f a physiological 
contro l mechanism fo r m odulating the a c t iv ity  of the renin-angiotensin 
system?
8.2 B io c h e m ic a l c h a ra c te r is t ic s  o f  p lasm a in a c t iv e  re n in
Over the past decade, considerable a tten tion  has been paid to the 
ac tiva tab le  fo rm  of renin present in human plasma, pa rtly  because plasma is 
more accessible than renal tissue in c lin ica l s ituations, and pa rtly  because early 
studies, which demonstrated raised levels of c ircu la ting  inactive  renin in a 
patient w ith  a Wilms tumour (Day and, Leutscher, 1974) and in patients w ith  
assorted renal abnorm alities (Day and Luetscher, 1975), suggested a functiona l 
sign ificance fo r th is  m ate ria l. U n fo rtuna te ly , the extrem ely low concentration 
of inactive  renin in plasma has hindered its  characterisation. In normal 
individuals, the concentration of inactive  renin in plasma is about lOOpg/ml 
(assuming tha t, a fte r activa tion , its  spec ific  a c t iv ity  is the same as th a t o f
purified  renal renin). Therefore, assuming a recovery of 10%, the iso lation o f 
Im g  of plasma inactive  renin would require a p u rifica tion  of several hundred
m illio n fo ld  from  about 100,000 litre s  o f plasma. Nevertheless, pa rtia l
purifica tions of plasma inactive  renin have been reported by several workers
(Yokosawa et a l., 1979; M orim oto et al., 1980; Chang et a l., 1981; A tlas e t a l., 
1982b; Inagami e t 1982b; Hiwada et ^ . ,  1983; Hsueh e t a l., 1983). O f 
these procedures, the most successful was tha t reported by Inagami e t a l.,
(1982b), who used a com bination of hydrophobic in te rac tion  chromatography and 
im m unoa ffin ity  chromatography on anti-ren in  IgG-Sepharose to  achieve a 17,500- 
fo ld  p u rifica tio n  o f c ircu la ting  inactive  renin from  plasma.
Plasma and renal inactive  renins behave s im ila r ly  when applied to
Cibacron Blue-agarose, pepstatin-Sepharose, concanavalin A-Sepharose, anion
exchange resins and gels containing hydrophobic ligands. Both are com ple te ly
inactive  against renin substrate, but can be ac tiva ted  irreve rs ib ly  by lim ite d  
proteolysis and revers ib ly  by a c id ifica tion . In each case, the a c t iv ity  generated
by lim ite d  proteolysis is identica l to tha t of active  renal renin w ith  respect to
pH optim um  and reaction  k inetics. These properties are summarised in Table 
8.1.
One cha rac te ris tic  tha t distinguishes plasma inactive  renin from  renal 
inactive  renin is tha t the fo rm er has a greater apparent M r value by gel
f i lt ra t io n . Thus, plasma inactive  renin has an M r value o f around 56,000 by 
gel f i l t ra t io n  compared to the M r value o f around 50,000 obtained fo r renal 
inactive  renin (A tlas e t 1981). There are several possible explanations fo r 
th is  discrepancy. One is tha t plasma inactive  renin and renal inactive  renins 
d iffe r  m arkedly in th e ir  prim ary structures. However, th is  is unlike ly, given 
the s trik ing  s im ila ritie s  of th e ir other physiological properties and of the 
c a ta ly tic  properties of the activa ted  form s (Table 8.1). Moreover, c ircu la ting
active  renin also appears to have a greater M r value (48,000) by gel f i lt ra t io n
Table 8.1
P roperties  shared by Inactive  renins from  human renal 
cortex and plasma ^
Inactive  form s
1. Bound by C ibacron Blue-agarose
2. N o t bound by pepstatin -  Sepharose
3. Bound by concanavalin A -  Sepharose
4. Weak a f f in ity  fo r  anion exchange resins
5. Strong a f f in ity  fo r hydrophobic ligands
6. A c tiva ted  irreve rs ib ly  by trypsin  or pepsin
7. A c tiva te d  reversib ly by ac id ifica tion
A c tiva ted  form s produced by lim ite d  proteolysis ^
1. N o t bound by C ibacron blue-agarose
2. No a c t iv ity  against haemoglobin
3. w ith  human angiotensinogen (0.8 - 1.3pM)
4. pH optim um  w ith  human angiotensinogen (pH 5.5 -  6.0)
5. Inh ib ition  by pepstatin (K j = 2.5 - 3.5 uM)
6. Com plete inh ib ition  by an ti-ren in  antibodies ( t it re  fo r  50% 
inh ib ition  is 4 -  5 x 10" )
® data taken from  A tlas e t (1982b)
^ these properties are also shared by active  renal ren in .
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than active  renin ex trac ted  from  the kidney (A tlas et aL, 1981), so tha t o ther 
explanations must be considered. These include the possib ilities tha t:
1. Inactive  renin is p a rtia lly  degraded during tissue ex tra c tion
2. Renal inactive  renin is m odified by in te rac tion  w ith  a binding pro te in  
upon entering the c ircu la tion
3. The form s o f renin present in kidney and plasma d iffe r  in conform ation 
and/or exten t o f g lycosylation, both of which are fac to rs  known to  
a ffe c t M r estim ation by gel f i lt ra t io n .
I t  seems un like ly  tha t p ro teo ly tic  degradation o f inactive  renin during its  
ex trac tion  from  renal tissue would occur w ithou t its  simultaneous ac tiva tion . 
In addition, the ex trac tion  of renins from  kidney is generally carried out in the 
presence o f a va rie ty  o f proteinase inh ib itors in order to  prevent such 
degradation taking place. There is more reason to consider the possib ility  of 
m od ifica tion  by a binding prote in since such a substance does appear to  be 
present in the renal cortex o f various animal species. However, Murakami et 
al. (1980a) have shown tha t the renin binding prote in from  hog kidney can bind 
to  inactive  renin only a fte r  the la tte r  has been activa ted  by tryps in . A ttem p ts  
to  demonstrate the presence o f renin binding proteins in mouse plasma using 
^^^I-labe lled  mouse renal renin as a probe have shown tha t, w h ile  labelled renin 
w ill bind to  a number o f plasma proteins, i t  does so only i f  i t  is f ir s t  denatured 
w ith  guanidine hydrochloride and then renatured p rio r to  its  incubation w ith  
plasma (Poulsen et ^ . ,  1979a).
There is precedent fo r suggesting tha t a d iffe rence  in glycosylation 
m ight exist between secreted and tissue forms o f the same prote in since th is 
has been documented fo r  the a-subunit of the p itu ita ry  g lycoprote in hormones 
(Kourides et 1980). Both renal and plasma inactive  renins appear to  be 
glycoproteins, based on th e ir a b ility  to  bind concanavalin A (Table 8.1). There 
are at present, however, no data concerning the com position of the carbohydrate
component o f each o f these renins.
F ina lly , i t  is w e ll known tha t conform ational changes in proteins can 
lead to s ign ifican t changes in Stokes radius, and thus in the behaviour o f
proteins during gel f i lt ra t io n . In th is respect i t  is in te resting  to  note th a t the
Stokes radius o f inactive  renin is greater in ac id ified  plasma than in normal 
plasma (Hsueh et 1981). Recently, Inagami e t (1983) have reported the 
use o f electrophoresis in the presence o f SDS fo llow ed by im m unospecific
staining o f renin to  obtain Mp values fo r  renal and plasma inactive renins.
Both were found to have Mp values o f 49,000-50,000 suggesting tha t the size 
discrepancy noted by gel f i lt ra t io n  may indeed be due to  a d ifference in the 
conform ation o f inactive  renin in plasma and kidney. The above value (Mp 
49,000-50,000) is s im ila r to tha t obtained in the present study fo r  purified  renal 
inactive  renin (Mp 48,000). I t  is like ly , therefo re , tha t plasma inactive  renin 
is, like  renal inactive  renin, a renin zymogen.
8.3 Sources o f c ircu la tin g  in ac tive  renin
Since the source o f c ircu la ting  active  renin is the renal cortex, i t  is 
lik e ly  th a t c ircu la ting  inactive  renin is also derived, at least in part, from  the 
kidney. Nevertheless, whereas the concentration o f active  renin in renal vein 
samples is 10-20% higher than concurrent a rte ria l values (M illa r e t 1978), 
s im ila r arteriovenous differences in inactive  renin have been d if f ic u lt  to 
demonstrate. W ithout question, there are certa in  patients who seem to  secrete 
re la tiv e ly  large amounts o f inactive  renin from  the kidney (Birkenhager ^  a l., 
1978; D erkx e t ah, 1978b; M illa r e t 1978; Aoi e t ah, 1979). On the other 
hand, an apparent negative arteriovenous d iffe rence occurs frequently  in patients 
w ith  essential hypertension and in the contra la te ra l kidneys o f patients w ith  
un ila te ra l renovascular hypertension (Sealey et ^ . ,  1980).
I f  inactive  renin were secreted from  the kidney then one would expect 
to find  high concentrations o f inactive  renin in the venous e ffluen t from  the
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affec ted  kidneys of patients w ith  renovascular hypertension. In th is s ituation, 
the blood flow  through the kidney is reduced and thus inac tive  renin would be 
secreted in to  a dim inished volume of blood per un it tim e . R ecently, Hsueh et 
al. (1983) have examined the levels o f plasma inactive  ren in  in a group o f e ight 
patients w ith  renovascular hypertension. In a ll cases, the inactive renin 
concentration was s ig n ifica n tly  higher in renal venous blood than in in fe rio r vena 
caval blood.
Furthe r evidence th a t inactive  renin is released from  the kidney includes 
the presence o f inactive  renin in the perfusate obtained from  transplant kidneys 
(Atlas et a l., 1980) and the fa c t tha t the concentration o f inactive  renin in 
plasma fa lls  a fte r b ila te ra l nephrectomy (Derkx et ^ . ,  1978b). However, the 
presence o f inactive  renin in plasma obtained from  individuals who have been 
nephrectomised fo r  several years (Sealey et ^ . ,  1977; W einberger et 1977) 
indicates tha t there must be an extrarenal source o f inactive  renin as w e ll.
Inactive  renin has been found in the brain and in  the p itu ita ry  gland 
(Hirose et aL, 1979), and in am nio tic  f lu id  (Lumbers, 1971). Renin in human 
am nio tic f lu id  is almost exclusive ly inactive  and is very s im ila r to  c ircu la ting  
inactive  renin (Johnston et aL, 1979). A va ilab le  evidence suggests th a t 
am nio tic  f lu id  inac tive  renin is synthesized in the chorion (Symonds e t 1968; 
Acker e t ^ . ,  1982). Sustained increases in plasma inac tive  renin concentration 
occur throughout pregnancy (Skinner et 1975; Sealey e t aL, 1982b). I t  is 
possible th a t in th is  s itua tion , plasma inactive  renin may be p a rtly  derived from  
the chorion. F urther studies w ill be required to determ ine whether or not 
extrarenal sources o f inactive  renin contribu te  to  c ircu la tin g  inactive  renin in 
normal man.
8.4 Factors involved in the ac tiva tio n  of in ac tiv e  renin
As has been discussed in Chapter 1, renin belongs to the aspartic 
proteinase group o f enzymes. This group also includes the gastric proteinases
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pepsin and chymosin, both of which are synthesized as inactive  precursors. 
Under physiological conditions, the zymogens of pepsin and chymosin (pepsinogen 
and prochymosin) do not require the action o f other proteinases to  generate 
active  enzymes. In the acid environment of the stomach, pepsinogen undergoes 
a conform ational change which results in an in tram olecu lar cleavage in which a 
16 amino acid peptide is removed from  the N-term inus o f the zymogen. The 
active  species form ed (pseudopepsin) then activates other pepsinogen molecules 
(K ass ell and Kay, 1973; Hartsuck et 1977). During th is  conversion, several 
peptides containing a to ta l o f 44 amino acid residues are removed from  the 
amino term inus o f pepsinogen. Prochymosin, and cathepsinogen D (the zymogen 
of the lysosomal aspartic proteinase, cathepsin D) are also activa ted by an 
in tram o lecu la r mechanism at low pH (Pedersen et ^ . ,  1979; Puidzar and Turk, 
1981).
L ike  the zymogens c ited  above, inactive renin appears to  undergo a 
conform ational change at acid pH (Chapter 6). However, although renin 
a c t iv ity  can be detected i f  the ac id ified  zymogen is assayed rap id ly  at neutra l 
pH, th is ’ac tiva tion ' process is com plete ly reversib le. This find ing is not 
unexpected since the extrem e substrate sp e c ific ity  and com parative ly high pH 
optim um  exhibited by renin are inconsistent w ith  an in tram olecu lar ac tiva tion  
mechanism analogous to  tha t seen w ith  pepsinogen. C learly , therefore , the 
ac tiva tion  o f inactive  renin must, like  most other zymogen activa tion  reactions, 
involve the action o f a second proteinase.
The question as to  which enzyme or enzymes may be responsible fo r  the 
ac tiva tion  o f inactive  renin _in vivo has been investigated by examining the 
e ffe c t of p ro teo ly tic  enzymes on inactive  renin jn  v itro . This type o f study 
has shown tha t a number o f proteinases, including ce rta in  enzymes o f the 
coagulation and fib r in o ly t ic  systems, as w e ll as a va rie ty  o f tissue proteinases, 
are capable o f ac tiva ting  inactive  renin when added to  plasma, am niotic f lu id  or
Table 8.2
Proteinases reported to be activators  o f in ac tive  
renin in v itro
Proteinase Reference
8-Acrosin
Arg in ine esteropeptidase (gamma) 
subunit of nerve growth fa c to r
Cathepsins B, D and H
Glandular ka llik re in
Hageman fa c to r (fac to r X lla )
M eta lloprote inase from  B itis  
arlentans venom
Pepsin
Plasma ka llik re in
Plasmin
Streptokinase
Trypsin
Urokinase
M orris et aL (1980)
M orris aL (1981)
Luetscher e t ^  (1982)
Derkx et aL (1979)
Sealey e t (1979)
M orris and Lawrence (1980) 
M orris and Lumbers (1972) 
Sealey e t ^  (1979)
Osmond et ^  (1978) 
Schalekamp and Derkx (1981) 
M orris and Lumbers (1972) 
Schalekamp and Derkx (1981)
kidney extracts  (Table 8.2). However, there are several points which must be 
taken Into account when in te rp re ting  the results o f such experiments. F irs t ly , 
several studies o f th is  type have used com m ercial proteinase preparations. 
Unless the pu rity  o f such enzymes is known, i t  is not certa in  whether any 
ac tiva tion  o f inactive  renin which is observed is due to  tha t pa rticu la r 
proteinase, or to a contam inating enzyme. Secondly, studies in which the 
e ffe c ts  o f proteinases are carried out using crude preparations o f inactive  renin 
are com plicated by the possible involvem ent o f other components in the m ate ria l 
under investigation. Plasma, fo r example, contains a large number o f 
proteinase inh ib ito rs  and thus re la tive ly  high concentrations o f a given proteinase 
may be required to  ac tiva te  inactive  renin in plasma. A fu rth e r problem w ith  
the use o f plasma to test puta tive  activa tors o f inactive  renin is tha t the 
proteinases under investigation may act in d ire c tly  by ac tiva tin g  an endogenous 
proteinase zymogen ra the r than by d ire c tly  ac tiva ting  inactive  renin. Inagami 
e t al. (1982b), fo r  example, have shown tha t throm bin, urokinase and activa ted  
Hageman fa c to r (fac to r XIIa), which ac tiva te  inactive  renin when added to  whole 
plasma, do not ac tiva te  p a rtia lly  pu rified  inactive  renin.
A second approach has been to  investigate the enzymes tha t ac tiva te  
inactive  renin when plasma is dialysed to acid pH and then back to  neutra l pH 
(Section 1.3(b)). Two endogenous serine proteinases, ac tiva ted  Hageman fa c to r 
(fac to r X lla ) and ka llik re in , have been im p lica ted  in th is  process. The 
activa tion  o f inactive  renin which is produced by the above procedure does not 
occur in plasma de fic ien t e ithe r in fa c to r X II or p reka llik re in . This find ing and 
the results of studies on the ac tiva tion  o f inactive  renin in fractiona ted  and 
reconstitu ted  plasmas have led Sealey e t (1979) to  suggest tha t plasma 
inactive  renin can be activa ted by a cascade mechanism in which Hageman 
fa c to r activates inactive  renin via the activa tion  o f p reka llik re in  (Figure 8.1).
Both Hageman fa c to r and ka llik re in  are norm ally present in plasma as
normal  pla sm a
Hagemon factor
{ Inhibitor-Kallikrein) ^
Prorenin
Kollikrein 
X #
HFf
Remn
( Inhibitor HFf )
Prekallikrein
A C[D-TRBATED PLASMA 
Hagemon focîor ■■
(Inhibitor • Kallikrein) — Kallikrein
 *
♦■■■iiiili w il l  Pr
(Inhibitor-HFf )
ekallikrein
Prorenin ► Renin
F igure  8.1 Proposed cascade mechanism fo r the Hagem an fa c to r -  
dependent ac tiva tio n  of in ac tiv e  renin (prorenin) in 
ac id ified  plasma as compared to norm al plasma^.
Heavy arrows ind icate the predominant pathway in each case H F f, active  
Hageman fa c to r fragm ents. * ,  K a llik re in  may ac tiva te  prorenin e ither d ire c tly  
or in d ire c tly , ®Taken from  Sealey et al. (1979).
inac tive  precursors. Hageman fa c to r is activa ted on contact w ith  negatively 
charged surfaces and the activa ted Hageman fa c to r can then convert 
p reka llik re in  to  ka llik re in . K a llik re in , in turn , accelerates the ra te  o f Hageman 
fa c to r ac tiva tion . Thus, the two enzymes and the ir precursors fo rm  a positive 
feedback loop which would resu lt in the rapid ac tiva tion  o f the en tire  pool of 
precursors were i t  not fo r  the fa c t tha t the a c t iv ity  o f these enzymes is 
norm ally  m aintained at low levels by plasma proteinase inh ib ito rs . Many o f 
these inh ib ito rs , and in pa rticu la r inh ib ito r and a 2 -m acroglobulin , which
in h ib it activa ted  Hageman fa c to r and ka llik re in  respective ly, are denatured at 
low pH (Derkx e t ^ . ,  1982). Thus, i f  plasma is ac id ified  and then returned to  
neutra l pH, there is a rapid generation of active  k a llik re in  which can then 
ac tiva te  inactive  renin.
8.5 Speculations concerning the ac tiva tio n  of in ac tiv e  renin  m vivo
W hile i t  is clear th a t a va rie ty  o f proteinases are capable o f ac tiva ting  
inactive  renin In v it ro , l i t t le  is known about the ac tiva tion  o f the renin zymogen 
in v ivo . Inactive  renin m ight m erely be a ce llu la r in term edia te  in renin 
biosynthesis. I f  th is  were the case, then its  ac tiva tio n  would occur p rio r to  
secretion and renin would be released from  the ce ll almost exclusively in the 
active  fo rm . However, as discussed above (Section 8.3), curren t evidence 
suggests tha t s ign ifican t quantities o f inactive  renin are released in to  the 
c ircu la tion . In view o f the fa c t th a t such a large proportion (up to  90%) o f 
the to ta l c ircu la ting  renin is present as the inactive  fo rm  of the enzyme, i t  is 
tem pting  to suggest tha t th is  m a te ria l has a functiona l s ign ificance and th a t the 
ac tiva tion  o f inac tive  renin a fte r its  release from  the ce ll m ight fo rm  the basis 
o f a contro l mechanism fo r m odulating the a c t iv ity  o f the renin-angiotensin 
system.
The find ing  th a t plasma inactive  renin can be ac tiva ted  by glandular 
(renal) ka llik re in  in v itro  has led to speculation th a t th is  enzyme m ight be
im portan t in the in tra rena l ac tiva tion  o f inactive  renin a fte r  its  release from  
the ce ll. However, some investigators have reported tha t glandular ka llik re in  is 
a re la tiv e ly  poor ac tiva to r o f inactive  renin (Hsueh et aL, 1981; Inagami et 
1982b). Furtherm ore, exam ination o f the d is tribu tion  o f glandular ka llik re in  and 
renin in the kidney by the Immunohistochem ical sta in ing o f sections o f ra t renal 
co rtex has shown th a t the two enzymes are located in d iffe re n t regions o f the 
nephron, and thus are un like ly to  in te ra c t jn  vivo (O rstavvik and Inagami, 1982).
I t  is o ften  suggested th a t the coagulation and f ib r in o ly t ic  cascades are 
continously active , and th a t both systems are in a dynamic equilibrium  which 
maintains an in ta c t and patent vascular tree . I t  is possible, therefo re , tha t 
one or more o f the enzymes belonging to these systems m ight activa te  inactive  
renin jn  v ivo . C e rta in ly , activa ted  Hageman fa c to r (fa c to r X lla ) and plasma 
ka llik re in  are po tentia l activa tors  of c ircu la ting  inactive  renin (Sealey e t
1979). Schalekamp and Derkx (1981) have suggested th a t plasmin m ight also be
an im portan t ac tiva to r o f the c ircu la ting  renin zymogen.
The possible pa rtic ipa tion  o f plasma ka llik re in  in the activa tion  o f
c ircu la ting  inactive  renin is supported by two observations. A positive 
corre la tion  exists between c ircu la ting  plasma p reka llik re in  levels and the
proportion o f active  renin in the c ircu la tion  (Rumpf e t ah, 1980). In addition, 
the proportion o f ac tive  renin in the c ircu la tion  is very low  in some patients 
w ith  p reka llik re in  de fic iency (Rumpf et ^ . ,  1980; Schalekamp and Derkx, 1981), 
suggesting tha t in these individuals the conversion o f inactive  renin to active
renin is abnormal.
Nevertheless, i t  is un like ly th a t the conversion o f inactive  renin to
active  renin would occur in c ircu la ting  plasma in which the ac tiv ities  o f the
coagulation, f ib r in o ly t ic  and ka llik re in -k in in  systems are m aintained at low levels 
by endogenous proteinase inh ib ito rs. I t  is more like ly  th a t such conversion 
would occur only at re s tr ic te d  sites w ith in  the vasculature, perhaps on the
surface o f blood vessels, or around f ib r in  clo ts, where the  local generation o f 
active  Hageman fa c to r, ka llik re in  or plasmin can occur.
C urrent evidence suggests tha t there is indeed l i t t le  system ic ac tiva tion  
o f inactive  renin. Experiments in which the levels o f c ircu la ting  active renin 
are a ltered by physiological or pharmacological m anipulations have, in general, 
fa ile d  to  demonstrate reciproca l changes in the levels o f c ircu la ting  inac tive  
renin (Leckie, 1981). For example, d ie ta ry  sodium depletion and d iu re tic  
therapy, both o f which stim u la te  the synthesis and release o f ac tive  renin, have 
been shown to  cause sm all, but s ign ifican t increases in c ircu la tin g  inactive renin 
levels (Sealey ^  ^ . ,  1980). This data is consistent w ith  the hypothesis tha t 
c ircu la ting  levels o f inactive  renin are regulated m ain ly by its  synthesis and 
release from  the kidney, or from  extra rena l sites o f ren in synthesis ra ther than 
by its  conversion to  active  renin w ith in  the c ircu la tion .
C learly , fu rth e r studies w ill be required to c la r ify  the physiological ro le  
o f the renin precursor.
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